e10vq
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-Q
|
|
|
(Mark One)
|
|
|
þ
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the quarterly period ended
March 31, 2009
|
OR
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period from
to
|
Commission file
number: 1-32381
HERBALIFE LTD.
(Exact name of registrant as
specified in its charter)
|
|
|
Cayman Islands
(State or other jurisdiction
of
incorporation or organization)
|
|
98-0377871
(I.R.S. Employer
Identification No.)
|
P.O. Box 309GT
Ugland House, South Church Street
Grand Cayman, Cayman Islands
(Address of principal
executive offices) (Zip code)
(310) 410-9600
(Registrants telephone
number, including area code)
Indicate by check mark whether the registrant: (1) has
filed all reports required to be filed by Section 13 or
15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any,
every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of
Regulation S-T
(§ 232.405 of this chapter) during the preceding
12 months (or for such shorter period that the registrant
was required to submit and post such
files). Yes o No o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in Rule
12b-2 of the
Exchange Act. (Check one):
|
|
|
|
Large
accelerated
filer þ
|
Accelerated
filer o
|
Non-accelerated
filer o
|
Smaller
reporting
company o
|
(Do not check if a smaller reporting company)
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the Exchange
Act). Yes o No þ
Number of shares of registrants common shares outstanding
as of April 30, 2009 was 61,548,112
PART I.
FINANCIAL INFORMATION
|
|
Item 1.
|
FINANCIAL
STATEMENTS
|
HERBALIFE
LTD.
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands, except share amounts)
|
|
|
ASSETS
|
CURRENT ASSETS:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
194,733
|
|
|
$
|
150,847
|
|
Receivables, net of allowance for doubtful accounts of $8,639
(2009) and $8,988 (2008)
|
|
|
72,300
|
|
|
|
70,002
|
|
Inventories, net
|
|
|
115,705
|
|
|
|
134,392
|
|
Prepaid expenses and other current assets
|
|
|
84,904
|
|
|
|
89,214
|
|
Deferred income taxes
|
|
|
39,921
|
|
|
|
40,313
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
507,563
|
|
|
|
484,768
|
|
|
|
|
|
|
|
|
|
|
Property, at cost, net of accumulated depreciation and
amortization of $100,260 (2009) and $89,411 (2008)
|
|
|
174,255
|
|
|
|
175,492
|
|
Deferred compensation plan assets
|
|
|
15,142
|
|
|
|
15,754
|
|
Deferred financing costs, net of accumulated amortization of
$1,408 (2009) and $1,287 (2008)
|
|
|
1,868
|
|
|
|
1,989
|
|
Marketing related intangibles
|
|
|
310,060
|
|
|
|
310,060
|
|
Goodwill
|
|
|
110,677
|
|
|
|
110,677
|
|
Other assets
|
|
|
20,961
|
|
|
|
22,578
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
1,140,526
|
|
|
$
|
1,121,318
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY
|
CURRENT LIABILITIES:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
29,853
|
|
|
$
|
41,084
|
|
Royalty overrides
|
|
|
125,696
|
|
|
|
130,369
|
|
Accrued compensation
|
|
|
43,690
|
|
|
|
60,629
|
|
Accrued expenses
|
|
|
114,590
|
|
|
|
104,795
|
|
Current portion of long-term debt
|
|
|
6,353
|
|
|
|
15,117
|
|
Advance sales deposits
|
|
|
28,903
|
|
|
|
12,603
|
|
Income taxes payable
|
|
|
44,052
|
|
|
|
37,302
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
393,137
|
|
|
|
401,899
|
|
|
|
|
|
|
|
|
|
|
NON-CURRENT LIABILITIES:
|
|
|
|
|
|
|
|
|
Long-term debt, net of current portion
|
|
|
339,126
|
|
|
|
336,514
|
|
Deferred compensation
|
|
|
13,773
|
|
|
|
13,979
|
|
Deferred income taxes
|
|
|
104,331
|
|
|
|
103,675
|
|
Other non-current liabilities
|
|
|
23,621
|
|
|
|
23,520
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
873,988
|
|
|
|
879,587
|
|
|
|
|
|
|
|
|
|
|
CONTINGENCIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS EQUITY:
|
|
|
|
|
|
|
|
|
Common shares, $0.002 par value, 500.0 million shares
authorized, 61.6 million (2009) and 61.4 million
(2008) shares issued and outstanding
|
|
|
123
|
|
|
|
123
|
|
Paid-in-capital
in excess of par value
|
|
|
201,973
|
|
|
|
197,715
|
|
Accumulated other comprehensive loss
|
|
|
(37,307
|
)
|
|
|
(28,614
|
)
|
Retained earnings
|
|
|
101,749
|
|
|
|
72,507
|
|
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
|
266,538
|
|
|
|
241,731
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$
|
1,140,526
|
|
|
$
|
1,121,318
|
|
|
|
|
|
|
|
|
|
|
See the accompanying notes to consolidated financial statements
3
HERBALIFE
LTD.
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(Unaudited)
|
|
|
|
(In thousands, except per share amounts)
|
|
|
Product sales
|
|
$
|
446,948
|
|
|
$
|
520,726
|
|
Handling & freight income
|
|
|
74,735
|
|
|
|
83,711
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
521,683
|
|
|
|
604,437
|
|
Cost of sales
|
|
|
102,400
|
|
|
|
117,666
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
419,283
|
|
|
|
486,771
|
|
Royalty overrides
|
|
|
175,532
|
|
|
|
212,720
|
|
Selling, general & administrative expenses
|
|
|
181,458
|
|
|
|
184,400
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
62,293
|
|
|
|
89,651
|
|
Interest expense, net
|
|
|
1,712
|
|
|
|
3,791
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
60,581
|
|
|
|
85,860
|
|
Income taxes
|
|
|
19,039
|
|
|
|
23,493
|
|
|
|
|
|
|
|
|
|
|
NET INCOME
|
|
$
|
41,542
|
|
|
$
|
62,367
|
|
|
|
|
|
|
|
|
|
|
Earnings per share:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.68
|
|
|
$
|
0.97
|
|
Diluted
|
|
$
|
0.67
|
|
|
$
|
0.93
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
|
Basic
|
|
|
61,510
|
|
|
|
64,381
|
|
Diluted
|
|
|
61,614
|
|
|
|
67,200
|
|
Dividends declared per share
|
|
$
|
0.20
|
|
|
$
|
0.20
|
|
See the accompanying notes to consolidated financial statements
4
HERBALIFE,
LTD.
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(Unaudited)
|
|
|
|
(In thousands)
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
41,542
|
|
|
$
|
62,367
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
14,821
|
|
|
|
10,371
|
|
Deficiency (Excess) tax benefits from share-based payment
arrangements
|
|
|
963
|
|
|
|
(10,709
|
)
|
Share based compensation expenses
|
|
|
4,880
|
|
|
|
5,133
|
|
Amortization of discount and deferred financing costs
|
|
|
121
|
|
|
|
118
|
|
Deferred income taxes
|
|
|
586
|
|
|
|
(92
|
)
|
Unrealized foreign exchange transaction loss
|
|
|
6,537
|
|
|
|
1,926
|
|
Other
|
|
|
919
|
|
|
|
556
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Receivables
|
|
|
(4,047
|
)
|
|
|
(13,843
|
)
|
Inventories
|
|
|
12,235
|
|
|
|
7,734
|
|
Prepaid expenses and other current assets
|
|
|
979
|
|
|
|
(16,482
|
)
|
Other assets
|
|
|
750
|
|
|
|
(77
|
)
|
Accounts payable
|
|
|
(9,566
|
)
|
|
|
(3,182
|
)
|
Royalty overrides
|
|
|
(1,035
|
)
|
|
|
(4,156
|
)
|
Accrued expenses and accrued compensation
|
|
|
(6,703
|
)
|
|
|
4,965
|
|
Advance sales deposits
|
|
|
16,666
|
|
|
|
6,242
|
|
Income taxes payable
|
|
|
6,574
|
|
|
|
12,184
|
|
Deferred compensation plan liability
|
|
|
(206
|
)
|
|
|
(255
|
)
|
|
|
|
|
|
|
|
|
|
NET CASH PROVIDED BY OPERATING ACTIVITIES
|
|
|
86,016
|
|
|
|
62,800
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
Purchases of property
|
|
|
(14,073
|
)
|
|
|
(23,931
|
)
|
Deferred compensation plan assets
|
|
|
612
|
|
|
|
330
|
|
|
|
|
|
|
|
|
|
|
NET CASH USED IN INVESTING ACTIVITIES
|
|
|
(13,461
|
)
|
|
|
(23,601
|
)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
Dividends paid
|
|
|
(12,300
|
)
|
|
|
(12,869
|
)
|
Borrowings from long-term debt
|
|
|
19,000
|
|
|
|
|
|
Principal payments on long-term debt
|
|
|
(25,487
|
)
|
|
|
(32,099
|
)
|
Increase in deferred financing costs
|
|
|
|
|
|
|
(75
|
)
|
Share repurchases
|
|
|
|
|
|
|
(17,668
|
)
|
(Deficiency) Excess tax benefits from share-based payment
arrangements
|
|
|
(963
|
)
|
|
|
10,709
|
|
Proceeds from exercise of stock options and sale of stock under
employee stock purchase plan
|
|
|
365
|
|
|
|
12,553
|
|
|
|
|
|
|
|
|
|
|
NET CASH USED IN FINANCING ACTIVITIES
|
|
|
(19,385
|
)
|
|
|
(39,449
|
)
|
|
|
|
|
|
|
|
|
|
EFFECT OF EXCHANGE RATE CHANGES ON CASH
|
|
|
(9,284
|
)
|
|
|
3,989
|
|
|
|
|
|
|
|
|
|
|
NET CHANGE IN CASH AND CASH EQUIVALENTS
|
|
|
43,886
|
|
|
|
3,739
|
|
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
|
|
|
150,847
|
|
|
|
187,407
|
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS, END OF PERIOD
|
|
$
|
194,733
|
|
|
$
|
191,146
|
|
|
|
|
|
|
|
|
|
|
CASH PAID DURING THE PERIOD
|
|
|
|
|
|
|
|
|
Interest paid
|
|
$
|
3,429
|
|
|
$
|
4,976
|
|
|
|
|
|
|
|
|
|
|
Income taxes paid
|
|
$
|
13,374
|
|
|
$
|
11,411
|
|
|
|
|
|
|
|
|
|
|
NON CASH ACTIVITIES
|
|
|
|
|
|
|
|
|
Assets acquired under capital leases and other long-term debt
|
|
$
|
280
|
|
|
$
|
657
|
|
|
|
|
|
|
|
|
|
|
See the accompanying notes to consolidated financial statements
5
HERBALIFE
LTD.
(Unaudited)
Herbalife Ltd., a Cayman Islands exempted limited liability
company, or Herbalife, incorporated on April 4, 2002.
Herbalife Ltd. (and together with its subsidiaries, the
Company) is a leading global network marketing
company that sells weight management, nutritional supplement,
energy, sports & fitness products and personal care
products through a network of over 1.9 million independent
distributors, except in China, where the Company currently sells
its products through retail stores and an employed sales force.
The Company reports revenue in six geographic regions: North
America, which consists of the U.S., Canada and Jamaica; Mexico;
South and Central America; EMEA, which consists of Europe, the
Middle East and Africa; Asia Pacific (excluding China) which
consists of Asia, New Zealand and Australia; and China.
The unaudited interim financial information of the Company has
been prepared in accordance with Article 10 of the
Securities and Exchange Commissions
Regulation S-X.
Accordingly, it does not include all of the information required
by generally accepted accounting principles, or GAAP, in the
U.S. for complete financial statements. The Companys
unaudited consolidated financial statements as of March 31,
2009, and for the three months ended March 31, 2009 and
2008, include Herbalife and all of its direct and indirect
subsidiaries. In the opinion of management, the accompanying
financial information contains all adjustments, consisting of
normal recurring adjustments, necessary to present fairly the
Companys unaudited consolidated financial statements as of
March 31, 2009, and for the three months ended
March 31, 2009 and 2008. These unaudited consolidated
financial statements should be read in conjunction with the
Companys Annual Report on
Form 10-K
for the year ended December 31, 2008, or the 2008
10-K.
Operating results for the three months ended March 31,
2009, are not necessarily indicative of the results that may be
expected for the year ending December 31, 2009.
Recently
Adopted Accounting Pronouncements
In March 2008, the Financial Accounting Standards Board, or
FASB, issued Statement of Financial Accounting Standards, or
SFAS, No. 161, Disclosures about Derivative Instruments
and Hedging Activities An Amendment of FASB
Statement No. 133, or SFAS 161. SFAS 161
expands the disclosure requirements for derivative instruments
and hedging activities. SFAS 161 specifically requires
entities to provide enhanced disclosures addressing the
following: (a) how and why an entity uses derivative
instruments, (b) how derivative instruments and related
hedged items are accounted for under SFAS No. 133,
Accounting for Derivative Instruments and Hedging Activities,
or SFAS 133, and its related interpretations, and
(c) how derivative instruments and related hedged items
affect an entitys financial position, financial
performance, and cash flows. SFAS 161 is effective for
fiscal years and interim periods beginning after
November 15, 2008. The Company adopted SFAS 161 on
January 1, 2009. The adoption had no financial impact on
the Companys consolidated financial statements and only
required additional financial statement disclosures. The Company
has applied the requirements of SFAS 161 on a prospective
basis. Accordingly, disclosures related to interim and annual
periods prior to the date of adoption have not been presented.
In February 2008, the FASB issued FASB Staff Position
FAS 157-2,
or FSP
FAS 157-2.
FSP
FAS 157-2
delayed the effective date of SFAS No. 157, Fair
Value Measurements, or SFAS 157, for all nonfinancial
assets and nonfinancial liabilities, except those that are
recognized or disclosed at fair value in the financial
statements on a recurring basis (at least annually). FSP
FAS 157-2
partially defers the effective date of SFAS 157 to fiscal
years beginning after November 15, 2008, and interim
periods within those fiscal years for items within the scope of
FSP FAS 157-2.
On January 1, 2009, the Company adopted the provisions of
SFAS 157 for nonfinancial assets and nonfinancial
liabilities and the adoption did not have a material impact on
its consolidated financial statements.
In December 2007, the FASB issued SFAS, No. 141 (revised
2007), Business Combinations, or SFAS 141R, which
replaces SFAS 141, Business Combinations.
SFAS 141R establishes principles and requirements for how
an
6
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
acquirer recognizes and measures in its financial statements the
identifiable assets acquired, the liabilities assumed, any non
controlling interest in the acquiree and the goodwill acquired.
SFAS 141R also modifies the recognition for preacquisition
contingencies, such as environmental or legal issues,
restructuring plans and acquired research and development value
in purchase accounting. SFAS 141R amends
SFAS No. 109, Accounting for Income Taxes, to
require the acquirer to recognize changes in the amount of its
deferred tax benefits that are recognizable because of a
business combination either in income from continuing operations
in the period of the combination or directly in contributed
capital, depending on the circumstances. SFAS 141R also
establishes disclosure requirements which will enable users to
evaluate the nature and financial effects of the business
combination. SFAS 141R is effective for fiscal years
beginning after December 15, 2008. The Company adopted
SFAS 141R on January 1, 2009 and the adoption did not
have a material impact on its consolidated financial statements.
New
Accounting Pronouncements
In April 2009, the FASB issued FASB Staff Position
No. FAS 107-1
and Accounting Principles Board Opinion
No. 28-1,
Interim Disclosures about Fair Value of Financial
Instruments, or FSP
FAS 107-1.
FSP
FAS 107-1
amends FASB Statement No. 107, Disclosures about Fair
Value of Financial Instruments, to require disclosures about
fair value of financial instruments for interim reporting
periods of publicly traded companies as well as in annual
financial statements. FSP
FAS 107-1
also amends Accounting Principles Board Opinion No. 28,
Interim Financial Reporting, to require those disclosures
in summarized financial information at interim reporting
periods. FSP
FAS 107-1
shall be effective for interim reporting periods ending after
June 15, 2009, with early adoption permitted for periods
ending after March 15, 2009. The Company has elected to
adopt FSP
FAS 107-1
for its interim period ending June 30, 2009, and believes
the adoption of FSP
FAS 107-1
will not have a material impact to its consolidated financial
statements.
Long-term debt consists of the following:
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
|
March 31,
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Borrowings under senior secured credit facility
|
|
$
|
328.5
|
|
|
$
|
324.5
|
|
Capital leases
|
|
|
6.3
|
|
|
|
6.9
|
|
Other debt
|
|
|
10.7
|
|
|
|
20.2
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
345.5
|
|
|
|
351.6
|
|
Less: current portion
|
|
|
6.4
|
|
|
|
15.1
|
|
|
|
|
|
|
|
|
|
|
Long-term portion
|
|
$
|
339.1
|
|
|
$
|
336.5
|
|
|
|
|
|
|
|
|
|
|
Interest expense was $3.3 million and $5.5 million for
the three months ended March 31, 2009 and 2008,
respectively.
On July 21, 2006, the Company entered into a
$300.0 million senior secured credit facility, comprised of
a $200.0 million term loan and a $100.0 million
revolving credit facility, with a syndicate of financial
institutions as lenders and replaced a $225.0 million
senior secured credit facility, originally entered into on
December 21, 2004. In September 2007, the Company and its
lenders amended the senior secured credit facility, increasing
the amount of the revolving credit facility by an aggregate
principal amount of $150.0 million to $250.0 million.
The term loan bears interest at LIBOR plus a margin of 1.5%, or
the base rate plus a margin of 0.50%, and matures on
July 21, 2013. The revolving credit facility bears interest
at LIBOR plus a margin of 1.25%, or the base rate plus a margin
of 0.25%, and is available until July 21, 2012. On
March 31, 2009 and December 31, 2008, the weighted
average interest rate for the senior secured credit facility was
2.20% and 3.04%, respectively.
7
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The senior secured credit facility requires the Company to
comply with a leverage ratio and an interest coverage ratio. In
addition, the senior secured credit facility contains customary
covenants, including covenants that limit or restrict the
Companys ability to incur liens, incur indebtedness, make
investments, dispose of assets, make certain restricted
payments, merge or consolidate and enter into certain
transactions with affiliates.
As of March 31, 2009, the Company is obligated to pay
approximately $0.4 million of the term loan every quarter
until June 30, 2013, and the remaining principal on
July 21, 2013. As of March 31, 2009 and
December 31, 2008, the amounts outstanding under the term
loan were $146.5 million and $146.8 million,
respectively.
During the first quarter of 2009, the Company borrowed an
additional $19.0 million under the revolving credit
facility and paid $14.7 million of the revolving credit
facility. As of March 31, 2009 and December 31, 2008,
the amounts outstanding under the revolving credit facility were
$182.0 million and $177.7 million, respectively.
Through the course of conducting regular business operations,
certain vendors and government agencies may require letters of
credit to be issued. As of March 31, 2009 and
December 31, 2008, the Company had $2.6 million and
$2.8 million, respectively, of issued but undrawn letters
of credit.
The Company is from time to time engaged in routine litigation.
The Company regularly reviews all pending litigation matters in
which it is involved and establishes reserves deemed appropriate
by management for these litigation matters when a probable loss
estimate can be made.
As a marketer of dietary and nutritional supplements and other
products that are ingested by consumers or applied to their
bodies, the Company has been and is currently subjected to
various product liability claims. The effects of these claims to
date have not been material to the Company, and the reasonably
possible range of exposure on currently existing claims is not
material to the Company. The Company believes that it has
meritorious defenses to the allegations contained in the
lawsuits. The Company currently maintains product liability
insurance with an annual deductible of $10 million.
Certain of the Companys subsidiaries have been subject to
tax audits by governmental authorities in their respective
countries. In certain of these tax audits, governmental
authorities are proposing that significant amounts of additional
taxes and related interest and penalties are due. The Company
and its tax advisors believe that there are substantial defenses
to their allegations that additional taxes are owed, and the
Company is vigorously contesting the additional proposed taxes
and related charges.
These matters may take several years to resolve, and the Company
cannot be sure of their ultimate resolution. However, it is the
opinion of management that adverse outcomes, if any, will not
likely result in a material adverse effect on the Companys
financial condition and operating results. This opinion is based
on the belief that any losses suffered in excess of amounts
reserved would not be material, and that the Company has
meritorious defenses. Although the Company has reserved an
amount that the Company believes represents the most likely
outcome of the resolution of these disputes, if the Company is
incorrect in the assessment the Company may have to record
additional expenses.
8
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Total comprehensive income consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Net income
|
|
$
|
41.5
|
|
|
$
|
62.4
|
|
Unrealized gain/(loss) on derivative instruments, net of tax
|
|
|
2.0
|
|
|
|
(0.9
|
)
|
Foreign currency translation adjustment
|
|
|
(10.7
|
)
|
|
|
1.0
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
$
|
32.8
|
|
|
$
|
62.5
|
|
|
|
|
|
|
|
|
|
|
The Company is a network marketing company that sells a wide
range of weight management products, nutritional supplements and
personal care products within one industry segment as defined
under SFAS No. 131, Disclosures about Segments of an
Enterprise and Related Information. The Companys
products are manufactured by third party providers and then sold
to independent distributors who sell Herbalife products to
retail consumers or other distributors.
The Company sells products in 70 countries throughout the world
and is organized and managed by geographic regions. The Company
aggregates its operating segments, excluding China, into one
reporting segment as management believes that the Companys
operating segments have similar operating characteristics and
similar long term operating performance. In making this
determination, management believes that the operating segments
are similar in the nature of the products sold, the product
acquisition process, the types of customers to whom products are
sold, the methods used to distribute the products, and the
nature of the regulatory environment. China has been identified
as a separate reportable segment as it does not meet the
criteria for aggregation.
Revenues reflect sales of products to distributors based on the
distributors geographic location.
9
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
During the first quarter of 2009, the Company changed its
geographic regions as part of the Companys restructuring
program by designating Mexico as its own region and combining
South America and Central America into one region. These changes
in geographic regions were implemented to create growth
opportunities for distributors, support faster decision making
across the organization by reducing the number of layers of
management, improve the sharing of ideas and tools and
accelerate growth in its high potential markets. Historical
information presented related to the Companys geographic
regions has been reclassified to conform with the current
geographic presentation. The operating information for the
Companys reporting segment and China, and sales by product
line are as follows:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Net Sales:
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
119.1
|
|
|
$
|
114.0
|
|
Mexico
|
|
|
59.2
|
|
|
|
93.6
|
|
China
|
|
|
26.8
|
|
|
|
24.5
|
|
Others
|
|
|
316.6
|
|
|
|
372.3
|
|
|
|
|
|
|
|
|
|
|
Total Net Sales
|
|
$
|
521.7
|
|
|
$
|
604.4
|
|
|
|
|
|
|
|
|
|
|
Operating Margin(1):
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
57.0
|
|
|
$
|
47.2
|
|
Mexico
|
|
|
26.3
|
|
|
|
38.8
|
|
China
|
|
|
22.6
|
|
|
|
22.4
|
|
Others
|
|
|
137.8
|
|
|
|
165.7
|
|
|
|
|
|
|
|
|
|
|
Total Operating Margin
|
|
$
|
243.7
|
|
|
$
|
274.1
|
|
Selling, general and administrative expense
|
|
|
181.5
|
|
|
|
184.4
|
|
Interest expense, net
|
|
|
1.7
|
|
|
|
3.8
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
60.5
|
|
|
|
85.9
|
|
Income taxes
|
|
|
19.0
|
|
|
|
23.5
|
|
|
|
|
|
|
|
|
|
|
Net Income
|
|
$
|
41.5
|
|
|
$
|
62.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Net sales by product line:
|
|
|
|
|
|
|
|
|
Weight Management
|
|
$
|
329.2
|
|
|
$
|
380.8
|
|
Targeted Nutrition
|
|
|
110.0
|
|
|
|
125.6
|
|
Energy, Sports & Fitness
|
|
|
21.6
|
|
|
|
24.0
|
|
Outer Nutrition
|
|
|
31.5
|
|
|
|
40.2
|
|
Literature, Promotional and Other(2)
|
|
|
29.4
|
|
|
|
33.8
|
|
|
|
|
|
|
|
|
|
|
Total Net Sales
|
|
$
|
521.7
|
|
|
$
|
604.4
|
|
|
|
|
|
|
|
|
|
|
Net sales by geographic region:
|
|
|
|
|
|
|
|
|
North America(3)
|
|
$
|
123.1
|
|
|
$
|
118.6
|
|
Mexico
|
|
|
59.2
|
|
|
|
93.6
|
|
South and Central America
|
|
|
75.3
|
|
|
|
106.0
|
|
EMEA(4)
|
|
|
123.3
|
|
|
|
158.0
|
|
Asia Pacific(5)
|
|
|
114.0
|
|
|
|
103.7
|
|
China
|
|
|
26.8
|
|
|
|
24.5
|
|
|
|
|
|
|
|
|
|
|
Total Net Sales
|
|
$
|
521.7
|
|
|
$
|
604.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Operating margin consists of net sales less cost of sales and
royalty overrides. |
10
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
(2) |
|
Product buybacks and returns in all product categories are
included in the literature, promotional and other category. |
|
(3) |
|
Consists of the U.S., Canada and Jamaica. |
|
(4) |
|
Consists of Europe, Middle East and Africa. |
|
(5) |
|
Consists of Asia (excluding China), New Zealand and Australia. |
As of March 31, 2009 and December 31, 2008, total
assets for the Companys reporting segment, excluding
China, was $1,096.1 million and $1,074.3 million,
respectively. Total assets for China were $44.4 million and
$47.0 million as of March 31, 2009 and
December 31, 2008, respectively.
|
|
7.
|
Stock
Based Compensation
|
The Company has five stock-based compensation plans, which are
more fully described in Note 9 to the Consolidated
Financial Statements in the 2008
10-K. During
the three months ended March 31, 2009, the Company granted
stock awards subject to continued service, consisting of stock
units and stock appreciation rights, with vesting terms fully
described in the 2008
10-K. During
the three months ended March 31, 2009, the Company also
granted stock units and stock appreciation rights, subject to
continued service, one-third of which vest on the third
anniversary of the date of grant, one-third of which vest on the
fourth anniversary of the date of grant, and the remaining
one-third of which vest on the fifth anniversary of the date of
grant.
For the three months ended March 31, 2009 and 2008,
stock-based compensation expense amounted to $4.9 million
and $5.1 million, respectively. As of March 31, 2009,
the total unrecognized compensation cost related to all
non-vested stock awards was $48.7 million and the related
weighted-average period over which it is expected to be
recognized is approximately 2.5 years.
The following tables summarize the activity under all
stock-based compensation plans for the three months ended
March 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Average
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Remaining
|
|
|
Aggregate
|
|
|
|
|
|
|
Exercise
|
|
|
Contractual
|
|
|
Intrinsic
|
|
Stock Options & SARS
|
|
Shares
|
|
|
Price
|
|
|
Term
|
|
|
Value
|
|
|
|
(In thousands)
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Outstanding at December 31, 2008
|
|
|
6,967
|
|
|
$
|
26.32
|
|
|
|
6.2 years
|
|
|
$
|
27.6
|
|
Granted
|
|
|
1,460
|
|
|
|
13.62
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(63
|
)
|
|
|
3.53
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
(127
|
)
|
|
|
29.03
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2009
|
|
|
8,237
|
|
|
$
|
24.20
|
|
|
|
6.6 years
|
|
|
$
|
9.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at March 31, 2009
|
|
|
4,125
|
|
|
$
|
19.00
|
|
|
|
5.2 years
|
|
|
$
|
7.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
|
|
|
|
|
|
Grant Date
|
|
|
Aggregate
|
|
Incentive Plan and Independent Directors Stock Units
|
|
Shares
|
|
|
Fair Value
|
|
|
Fair Value
|
|
|
|
(In thousands)
|
|
|
|
|
|
(In millions)
|
|
|
Outstanding and nonvested at December 31, 2008
|
|
|
476.3
|
|
|
$
|
43.41
|
|
|
$
|
20.7
|
|
Granted
|
|
|
411.0
|
|
|
|
13.64
|
|
|
|
5.6
|
|
Vested
|
|
|
(125.4
|
)
|
|
|
43.30
|
|
|
|
(5.4
|
)
|
Cancelled
|
|
|
(11.0
|
)
|
|
|
41.61
|
|
|
|
(0.5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding and nonvested at March 31, 2009
|
|
|
750.9
|
|
|
$
|
27.18
|
|
|
$
|
20.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The weighted-average grant date fair value of stock awards
granted during the three months ended March 31, 2009 and
2008 was $5.85 and $21.58, respectively. The total intrinsic
value of stock awards exercised during the three months ended
March 31, 2009 and 2008 was $1.2 million and
$32.9 million, respectively.
As of March 31, 2009, the total amount of unrecognized tax
benefits, related interest and penalties was $41.1 million,
$8.7 million and $3.2 million, respectively. During
the three months ended March 31, 2009, the Company recorded
tax and interest related to uncertain tax positions of
$0.1 million and $0.2 million, respectively. The
unrecognized tax benefits relate primarily to uncertainties from
international transfer pricing issues and the deductibility of
certain operating expenses in various jurisdictions. If the
total amount of unrecognized tax benefits were recognized,
$41.1 million of unrecognized tax benefits,
$8.7 million of interest and $3.2 million of
penalties, would impact the effective tax rate.
During the three months ended March 31, 2009, the Company
benefited from the terms of a tax holiday in the Peoples
Republic of China. The tax holiday commenced on January 1,
2008 and will conclude on December 31, 2012. Under the
terms of the holiday, the Company is subject to a zero tax rate
in China during 2008 and 2009 and a concessionary tax rate in
China for the remaining years included in the holiday period.
|
|
9.
|
Derivative
Instruments and Hedging Activities
|
Interest
Rate Risk Management
The Company engages in an interest rate hedging strategy for
which the hedged transactions are forecasted interest payments
on the Companys variable rate term loan. The hedged risk
is the variability of forecasted interest rate cash flows, where
the hedging strategy involves the purchase of interest rate
swaps. For the outstanding cash flow hedges on interest rate
exposures at March 31, 2009 the maximum length of time over
which the Company is hedging these exposures is approximately
six months.
Under its senior secured credit facility, the Company is
obligated to enter into interest rate hedges for up to 25% of
the aggregate principal amount of the term loan for a minimum of
three years. On August 23, 2006, the Company entered into
an interest rate swap agreement. The agreement provides for the
Company to pay interest for a three-year period at a fixed rate
of 5.26% on various notional amounts while receiving interest
for the same period at the LIBOR rate on the same notional
principal amounts. The swap has been designated as a cash flow
hedge against the variability in LIBOR interest rate on the new
term loan at LIBOR plus 1.50%, thereby fixing the Companys
effective rate on the notional amounts at 6.76%. The Company
formally assesses, both at inception and at least quarterly
thereafter, whether the derivatives used in hedging transactions
are effective in offsetting changes in cash flows of the hedged
item. As of March 31, 2009 and December 31, 2008, the
hedge relationship qualified as an effective hedge under
SFAS No. 133. Consequently, all changes in the fair
value of the derivative are deferred and recorded in other
comprehensive income (loss) until the related forecasted
transaction is recognized in the consolidated statements of
income. The fair value of the interest rate swap agreement is
based on third-party bank quotes and the Company recorded the
interest rate swap as a liability at fair value of
$0.6 million and $1.0 million as of March 31,
2009 and December 31, 2008, respectively.
Foreign
Currency Instruments
The Company also designates certain derivatives, such as certain
foreign currency forward and option contracts, as freestanding
derivatives for which hedge accounting does not apply. The
changes in the fair market value of the derivatives are included
in selling, general and administrative expenses in the
Companys consolidated statements of income. The Company
uses foreign currency forward contracts to hedge
foreign-currency-denominated intercompany transactions and to
partially mitigate the impact of foreign currency fluctuations.
The Company also uses foreign currency option contracts to
partially mitigate the impact of foreign currency fluctuations.
The fair value of the forward and option contracts are based on
third-party bank quotes. As of March 31, 2009, all of the
Companys outstanding foreign currency forward contracts
have maturity dates of less
12
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
than one year, with the majority maturing within 90 days.
There were no foreign currency option contracts outstanding as
of March 31, 2009. See Part I, Item 3
Quantitative and Qualitative Disclosures About Market Risk
in this Quarterly Report on
Form 10-Q
for foreign currency instruments outstanding as of
March 31, 2009.
The Company also purchases forward contracts in order to hedge
forecasted inventory purchases that are designated as cash-flow
hedges and are subject to foreign currency exposures. The
Company applied the hedge accounting rules as required by
SFAS 133 for these hedges. These contracts allow the
Company to sell Euros in exchange for US dollars at
specified contract rates. As of March 31, 2009,
approximately $36.0 million of these contracts were
outstanding and are expected to mature over the next nine
months. The Companys derivative financial instruments are
recorded on the consolidated balance sheet at fair value based
on quoted market rates. These forward contracts are used to
hedge forecasted inventory purchases over specific months.
Changes in the fair value of forward contracts, excluding
forward points, designated as cash-flow hedges are recorded in
other comprehensive income (loss), and are recognized in cost of
sales in the period which approximates the time the hedged
inventory is sold. As of March 31, 2009 and
December 31, 2008, the Company recorded an asset at fair
value of $1.5 million and a liability of $0.1 million,
respectively, relating to outstanding contracts. The Company
assesses hedge effectiveness and measures hedge ineffectiveness
at least quarterly. During the three months ended March 31,
2009, the ineffective portion relating to these hedges was
immaterial and the hedges remained effective as of
March 31, 2009.
Gains
and Losses on Derivative Instruments
The following gains (losses) relating to derivative instruments
were recorded in other comprehensive income (loss) during the
three months ended March 31, 2009:
|
|
|
|
|
|
|
|
|
Amount of Gain or
|
|
|
|
|
(Loss) Recognized
|
|
|
|
|
in Other
|
|
|
|
|
Comprehensive
|
|
|
|
|
Income (Loss)
|
|
|
|
|
(In millions)
|
|
|
|
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
Foreign exchange contracts
|
|
$
|
2.4
|
|
|
|
Interest rate contracts
|
|
|
|
|
|
|
The following gains (losses) relating to derivative instruments
were recorded to income during the three months ended
March 31, 2009:
|
|
|
|
|
|
|
|
|
Amount of Gain or
|
|
|
|
|
(Loss) Recognized
|
|
Location of Gain or (Loss)
|
|
|
in Income
|
|
Recognized in Income
|
|
|
(In millions)
|
|
|
|
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
Foreign exchange contracts(1)
|
|
$
|
(0.2
|
)
|
|
Selling, general and administrative expenses
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
Foreign exchange contracts
|
|
$
|
(0.3
|
)
|
|
Selling, general and administrative expenses
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
For foreign exchange contracts designated as hedging
instruments, the $0.2 million losses recognized in income
represents the amounts excluded from the assessment of hedge
effectiveness. There were no ineffective amounts reported for
derivatives designated as hedging instruments. |
13
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following gains (losses) relating to derivative instruments
were reclassified from accumulated other comprehensive loss into
income during the three months ended March 31, 2009:
|
|
|
|
|
|
|
|
|
Amount of Gain or
|
|
|
|
|
(Loss) Reclassified
|
|
|
|
|
from Accumulated
|
|
|
|
|
Other Comprehensive
|
|
Location of Gain or (Loss) Reclassified
|
|
|
Income (Loss) into
|
|
from Accumulated Other Comprehensive Income
|
|
|
Income
|
|
(Loss) into Income (Effective Portion)
|
|
|
(In millions)
|
|
|
|
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
Foreign exchange contracts
|
|
$
|
|
|
|
Cost of sales
|
Interest rate contracts
|
|
$
|
(0.4
|
)
|
|
Interest expense, net
|
SFAS 133 requires companies to recognize all derivative
instruments as either assets or liabilities at fair value in the
statement of financial position. See Note 13, Fair Value
Measurements, for information on derivative fair values in
the Companys consolidated balance sheet as of
March 31, 2009.
|
|
10.
|
Restructuring
Reserve
|
The Company recorded $0.6 million and $0.4 million of
professional fees, severance and related costs for the three
months ended March 31, 2009 and 2008, respectively, related
to restructurings. All such amounts were included in selling,
general and administrative expenses. The Company expects to
complete in 2009 the restructuring program initiated in the
fourth quarter of 2008.
The following table summarizes the components of this reserve as
of March 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retention
|
|
|
|
|
|
|
|
|
|
Severance
|
|
|
Benefits
|
|
|
Others
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Balance as of December 31, 2008
|
|
$
|
3.3
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
3.3
|
|
Charges
|
|
|
0.5
|
|
|
|
|
|
|
|
0.1
|
|
|
|
0.6
|
|
Cash payments
|
|
|
(2.6
|
)
|
|
|
|
|
|
|
(0.1
|
)
|
|
|
(2.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of March 31, 2009
|
|
$
|
1.2
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
1.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends
On February 20, 2009, the Companys board of directors
approved a quarterly cash dividend of $0.20 per common share in
an aggregate amount of $12.3 million, for the fourth
quarter of 2008 that was paid to shareholders of record on
March 17, 2009. The aggregate amount of dividends declared
and paid during the three months ended March 31, 2009 and
2008 were $12.3 million and $12.9 million,
respectively.
Share
Repurchases
During the three months ended March 31, 2009, the Company
did not repurchase any of its common shares. As of
March 31, 2009, since the inception of the share repurchase
program, the Company has repurchased approximately
13.7 million of its common shares at an aggregate cost of
$502.8 million or an average cost of $36.76 per share. As
of March 31, 2009, the approximate dollar value of shares
that could be purchased under the Companys share
repurchase program was approximately $97.2 million. The
Companys share repurchase program in effect on
March 31, 2009 expired on April 17, 2009 pursuant to
its terms.
Basic earnings per share represents net income for the period
common shares were outstanding, divided by the weighted average
number of common shares outstanding for the period. Diluted
earnings per share represents net
14
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
income divided by the weighted average number of common shares
outstanding, inclusive of the effect of dilutive securities such
as outstanding stock options, stock appreciation rights, stock
units and warrants.
The following are the common share amounts used to compute the
basic and diluted earnings per share for each period:
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
|
|
|
|
Ended March 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands)
|
|
|
Weighted average shares used in basic computations
|
|
|
61,510
|
|
|
|
64,381
|
|
Dilutive effect of exercise of equity grants outstanding
|
|
|
61
|
|
|
|
2,497
|
|
Dilutive effect of warrants
|
|
|
43
|
|
|
|
322
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in diluted computations
|
|
|
61,614
|
|
|
|
67,200
|
|
|
|
|
|
|
|
|
|
|
Equity grants, such as stock options, stock appreciation rights,
or stock units, to purchase or acquire 3.7 million and
1.5 million common shares were outstanding during the three
months ended March 31, 2009 and 2008, respectively, but
were not included in the computation of diluted earnings per
share because the exercise prices were greater than the average
market price of a common share and therefore such equity grants
would be anti-dilutive.
|
|
13.
|
Fair
Value Measurements
|
The Company currently applies the provisions of SFAS 157
for its financial and non-financial assets and liabilities.
SFAS 157 defines fair value as the price that would be
received to sell an asset or paid to transfer a liability in an
orderly transaction between market participants at the
measurement date. SFAS 157 establishes a fair value
hierarchy, which prioritizes the inputs used in measuring fair
value into three broad levels as follows:
Level 1 inputs are quoted prices (unadjusted) in active
markets for identical assets or liabilities that the reporting
entity has the ability to access at the measurement date.
Level 2 inputs include quoted prices for similar assets or
liabilities in active markets, quoted prices for identical or
similar assets or liabilities in markets that are not active,
inputs other than quoted prices that are observable for the
asset or liability and inputs that are derived principally from
or corroborated by observable market data by correlation or
other means.
Level 3 inputs are unobservable inputs for the asset or
liability.
The Company measures certain assets and liabilities at fair
value consisting of derivative instruments. All derivative
assets are recorded as prepaid expenses and other current
assets, and all derivative liabilities are recorded as accrued
expenses. Assets or liabilities that have recurring measurements
are shown below:
Fair
Value Measurements at Reporting Date Using
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in Active
|
|
|
Significant
|
|
|
|
|
|
|
|
|
|
|
|
Markets for
|
|
|
Other
|
|
|
Significant
|
|
|
|
|
|
|
|
|
Identical
|
|
|
Observable
|
|
|
Unobservable
|
|
|
|
Balance Sheet
|
|
March 31,
|
|
|
Assets/Liabilities
|
|
|
Inputs
|
|
|
Inputs
|
|
Description
|
|
Location
|
|
2009
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
|
(In millions)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives designated as cash flow hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts
|
|
Prepaid expenses and other current assets
|
|
$
|
1.5
|
|
|
$
|
|
|
|
$
|
1.5
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in Active
|
|
|
Significant
|
|
|
|
|
|
|
|
|
|
|
|
Markets for
|
|
|
Other
|
|
|
Significant
|
|
|
|
|
|
|
|
|
Identical
|
|
|
Observable
|
|
|
Unobservable
|
|
|
|
Balance Sheet
|
|
March 31,
|
|
|
Assets/Liabilities
|
|
|
Inputs
|
|
|
Inputs
|
|
Description
|
|
Location
|
|
2009
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
|
(In millions)
|
|
|
Total assets
|
|
|
|
$
|
1.5
|
|
|
$
|
|
|
|
$
|
1.5
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives designated as cash flow hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swap
|
|
Accrued expenses
|
|
$
|
0.6
|
|
|
$
|
|
|
|
$
|
0.6
|
|
|
$
|
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts
|
|
Accrued expenses
|
|
|
1.3
|
|
|
|
|
|
|
|
1.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
|
$
|
1.9
|
|
|
$
|
|
|
|
$
|
1.9
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On April 30, 2009, the Company announced that its board of
directors has authorized a $0.20 per common share cash dividend
for the first quarter of 2009, payable on June 5, 2009 to
shareholders of record on May 22, 2009.
The Companys share repurchase program in effect on March
31, 2009 expired on April 17, 2009 pursuant to its terms.
On April 30, 2009, the Company announced that its board of
directors authorized a new program for the Company to repurchase
up to $300 million of Herbalife common shares during the
next two years, at such times and prices as determined by the
Companys management.
16
|
|
Item 2.
|
Managements
Discussion and Analysis of Financial Condition and Results of
Operations
|
Overview
We are a global network marketing company that sells weight
management products, nutritional supplements, energy,
sports & fitness products and personal care products.
We pursue our mission of changing peoples
lives by providing a financially rewarding business
opportunity to distributors and quality products to distributors
and their customers who seek a healthy lifestyle. We are one of
the largest network marketing companies in the world with net
sales of approximately $2.4 billion for the year ended
December 31, 2008. As of March 31, 2009, we sold our
products in 70 countries through a network of over
1.9 million independent distributors. In China, we sell our
products through retail stores and an employed sales force. We
believe the quality of our products and the effectiveness of our
distribution network, coupled with geographic expansion, have
been the primary reasons for our success throughout our
29-year
operating history.
Our products are grouped in four principal categories: weight
management, targeted nutrition, energy, sports &
fitness and Outer Nutrition. Our products are often sold in
programs that are comprised of a series of related products
designed to simplify weight management and nutrition for
consumers and maximize our distributors cross-selling
opportunities.
Industry-wide factors that affect us and our competitors include
the increasing prevalence of obesity and the aging of the
worldwide population, which are driving demand for nutrition and
wellness-related products and the recruitment and retention of
distributors.
While we are closely monitoring the current global economic
crisis, the Company remains focused on the opportunities and
challenges in retailing of our products, recruiting and
retaining distributors, improving distributor productivity,
opening new markets, further penetrating existing markets
including China, the U.S., Brazil, Mexico and Russia,
globalizing successful distributor methods of operation such as
Nutrition Clubs, introducing new products, developing niche
market segments and further investing in our infrastructure.
Management remains intently focused on the Venezuela market and
especially the limited ability to repatriate cash at the
official exchange rate.
During the first quarter of 2009, we changed our geographic
regions, designating Mexico as its own region and combining
South America and Central America into a single region. These
changes in geographic regions were implemented to create growth
opportunities for distributors, support faster decision making
across the organization by reducing the number of layers of
management, improve the sharing of ideas and tools and
accelerate growth in high potential markets. Under the new
geographic regions, we report revenue from:
|
|
|
|
|
North America, which consists of the U.S., Canada and Jamaica;
|
|
|
|
Mexico;
|
|
|
|
South and Central America;
|
|
|
|
EMEA, which consists of Europe, the Middle East and Africa;
|
|
|
|
Asia Pacific, which consists of Asia (excluding China), New
Zealand and Australia; and
|
|
|
|
China.
|
Historical information presented in this Quarterly Report on
Form 10-Q
relating to our geographic regions has been reclassified to
conform with our current geographic presentation
Volume
Points by Geographic Region
A key non-financial measure we focus on is Volume Points on a
Royalty Basis, or Volume Points, which is essentially our
weighted unit measure of product sales volume. It is a useful
measure that we rely on as it excludes the impact of foreign
currency fluctuations and ignores the differences generated by
varying retail pricing across geographic markets. The Volume
Point measure, in the aggregate and in each region, can be a
measure of our sales volume as well as of sales volume trends.
In general, an increase in Volume Points in a particular
geographic region
17
or country indicates an increase in our sales volume which
results in an increase in our local currency net sales and a
decrease in Volume Points in a particular geographic region or
country indicates a decrease in our sales volume, which results
in decreasing local currency net sales.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
% Change
|
|
|
|
(Volume points in millions)
|
|
|
North America
|
|
|
186.5
|
|
|
|
178.1
|
|
|
|
4.7
|
%
|
Mexico
|
|
|
120.4
|
|
|
|
148.1
|
|
|
|
(18.7
|
)%
|
South and Central America
|
|
|
102.6
|
|
|
|
118.9
|
|
|
|
(13.7
|
)%
|
EMEA
|
|
|
124.1
|
|
|
|
137.1
|
|
|
|
(9.5
|
)%
|
Asia Pacific
|
|
|
145.0
|
|
|
|
106.3
|
|
|
|
36.4
|
%
|
China
|
|
|
20.8
|
|
|
|
20.7
|
|
|
|
0.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Worldwide
|
|
|
699.4
|
|
|
|
709.2
|
|
|
|
(1.4
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
New Sales Leaders by Geographic Region during the Reporting
Period
Another key non-financial measure on which we focus is the
number of distributors qualified as new sales leaders under our
compensation system. Excluding China, distributors qualify for
supervisor status based on their Volume Points. The changes in
the total number of sales leaders or changes in the productivity
of sales leaders may cause Volume Points to increase or
decrease. The fluctuation in the number of new sales leaders is
a general indicator of the level of distributor recruitment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
% Change
|
|
|
North America
|
|
|
7,893
|
|
|
|
9,010
|
|
|
|
(12.4
|
)%
|
Mexico
|
|
|
4,351
|
|
|
|
7,355
|
|
|
|
(40.8
|
)%
|
South and Central America
|
|
|
7,715
|
|
|
|
12,780
|
|
|
|
(39.6
|
)%
|
EMEA
|
|
|
5,236
|
|
|
|
6,533
|
|
|
|
(19.9
|
)%
|
Asia Pacific (excluding China)
|
|
|
10,737
|
|
|
|
8,777
|
|
|
|
22.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total New Supervisors
|
|
|
35,932
|
|
|
|
44,455
|
|
|
|
(19.2
|
)%
|
New China Sales Employees
|
|
|
4,327
|
|
|
|
4,350
|
|
|
|
(0.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Worldwide Total New Sales Leaders
|
|
|
40,259
|
|
|
|
48,805
|
|
|
|
(17.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Supervisors and Retention Rates by Geographic Region as of
Re-qualification Period
Our compensation system requires each supervisor to re-qualify
for such status each year, prior to February, in order to
maintain their 50% discount on product and be eligible to
receive royalty payments. In February of each year, we demote
from the rank of supervisor those distributors who did not
satisfy the supervisor re-qualification requirements during the
preceding twelve months. The re-qualification requirement does
not apply to new supervisors (i.e. those who became supervisors
subsequent to the January re-qualification of the prior year).
|
|
|
|
|
|
|
|
|
Supervisor Statistics (Excluding China)
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands)
|
|
|
January 1 total supervisors
|
|
|
456.9
|
|
|
|
451.6
|
|
January & February new supervisors
|
|
|
20.6
|
|
|
|
28.6
|
|
Demoted supervisors (did not re-qualify)
|
|
|
(181.4
|
)
|
|
|
(167.7
|
)
|
Other supervisors (resigned, etc)
|
|
|
(1.4
|
)
|
|
|
(2.8
|
)
|
|
|
|
|
|
|
|
|
|
End of February total supervisors
|
|
|
294.7
|
|
|
|
309.7
|
|
|
|
|
|
|
|
|
|
|
18
The distributor statistics below further highlight the
calculation for retention.
|
|
|
|
|
|
|
|
|
Supervisor Retention (Excluding China)
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands)
|
|
|
Supervisors needed to re-qualify
|
|
|
304.0
|
|
|
|
284.0
|
|
Demoted supervisors (did not re-qualify)
|
|
|
(181.4
|
)
|
|
|
(167.7
|
)
|
|
|
|
|
|
|
|
|
|
Total re-qualified
|
|
|
122.6
|
|
|
|
116.3
|
|
|
|
|
|
|
|
|
|
|
Retention rate
|
|
|
40.3
|
%
|
|
|
41.0
|
%
|
|
|
|
|
|
|
|
|
|
The table below reflects the number of sales leaders as of
February (subsequent to the annual re-qualification date) and
supervisor retention rate by year and by region.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Sales Leaders
|
|
|
Supervisors Retention Rate
|
|
|
|
2009
|
|
|
2008
|
|
|
2009
|
|
|
2008
|
|
|
North America
|
|
|
63,726
|
|
|
|
64,383
|
|
|
|
42.2
|
%
|
|
|
43.5
|
%
|
Mexico
|
|
|
50,099
|
|
|
|
60,685
|
|
|
|
45.2
|
%
|
|
|
44.4
|
%
|
South and Central America
|
|
|
67,876
|
|
|
|
67,808
|
|
|
|
32.2
|
%
|
|
|
34.7
|
%
|
EMEA
|
|
|
53,371
|
|
|
|
59,446
|
|
|
|
48.7
|
%
|
|
|
46.6
|
%
|
Asia Pacific (excluding China)
|
|
|
59,631
|
|
|
|
57,355
|
|
|
|
35.1
|
%
|
|
|
34.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Supervisors
|
|
|
294,703
|
|
|
|
309,677
|
|
|
|
40.3
|
%
|
|
|
41.0
|
%
|
China Sales Employees
|
|
|
29,684
|
|
|
|
25,294
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Worldwide Total Sales Leaders
|
|
|
324,387
|
|
|
|
334,971
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The number of supervisors by geographic region as of the
quarterly reporting dates will normally be higher than the
number of supervisors by geographic region as of the
re-qualification period because supervisors who do not
re-qualify during the relevant twelve-month period will be
dropped from the rank of supervisor the following February.
Since supervisors purchase most of our products for resale to
other distributors and consumers, comparisons of supervisor
totals on a year-to-year basis are good indicators of our
recruitment and retention efforts in different geographic
regions.
The value of the average monthly purchase of Herbalife products
by our sales leaders has remained relatively constant over time.
Consequently, increases in our sales are driven primarily by our
retention of supervisors and by our recruitment and retention of
distributors, rather than through increases in the productivity
of our overall supervisor base.
We provide distributors with products, support materials,
training, special events and a competitive compensation program.
If a distributor wants to pursue the Herbalife business
opportunity, the distributor is responsible for growing his or
her business and personally pays for the sales activities
related to attracting new customers and recruiting distributors
by hosting events such as Herbalife Opportunity Meetings or
Success Training Seminars; by advertising Herbalifes
products; by purchasing and using promotional materials such as
t-shirts, buttons and caps; by utilizing and paying for direct
mail and print material such as brochures, flyers, catalogs,
business cards, posters and banners and telephone book listings;
by purchasing inventory for sale or use as samples; and by
training, mentoring and following up (in person or via the phone
or internet) with customers and recruits on how to use Herbalife
products
and/or
pursue the Herbalife business opportunity.
Presentation
Retail sales represent the gross sales
amounts on our invoices to distributors before distributor
allowances, as defined below, and net sales, which
reflect distribution allowances and handling and freight income,
represent what we collect and recognize as net sales in our
financial statements. We discuss retail sales because of its
fundamental role in our compensation systems, internal controls
and operations, including its role as the basis upon which
distributor discounts, royalties and bonuses are awarded. In
addition, it is used as the basis for certain
19
information included in daily and monthly reports reviewed by
our management. However, such a measure is not in accordance
with Generally Accepted Accounting Principles in the U.S., or
GAAP. You should not consider retail sales in isolation from,
nor as a substitute for, net sales and other consolidated income
or cash flow statement data prepared in accordance with GAAP, or
as a measure of profitability or liquidity. A reconciliation of
net sales to retail sales is presented below under Results
of Operations. Product sales represent the
actual product purchase price paid to us by our distributors,
after giving effect to distributor discounts referred to as
distributor allowances, which approximate 50% of
retail sales prices. Distributor allowances as a percentage of
retail sales may vary by country depending upon regulatory
restrictions that limit or otherwise restrict distributor
allowances.
Our gross profit consists of net sales less
cost of sales, which represents the prices we pay to
our raw material suppliers and manufacturers of our products as
well as costs related to product shipments, duties and tariffs,
freight expenses relating to shipment of products to
distributors and importers and similar expenses.
Royalty overrides are our most significant
expense and consist of:
|
|
|
|
|
royalty overrides and production bonuses which total
approximately 15% and 7%, respectively, of the retail sales of
weight management, targeted nutrition, energy,
sports & fitness, Outer Nutrition and promotional
products;
|
|
|
|
the Mark Hughes bonus payable to some of our most senior
distributors in the aggregate amount of up to 1% of retail sales
of weight management, targeted nutrition, energy,
sports & fitness and Outer Nutrition; and
|
|
|
|
other discretionary incentive cash bonuses to qualifying
distributors.
|
Royalty overrides are generally earned based on retail sales and
approximate in the aggregate about 21% of retail sales or
approximately 34% of our net sales. Royalty overrides together
with distributor allowances represent the potential earnings to
distributors of up to approximately 73% of retail sales. The
compensation to distributors is generally for the development,
retention and improved productivity of their distributor sales
organizations and is paid to several levels of distributors on
each sale. Due to restrictions on direct selling in China, our
full-time employed sales representatives in China are
compensated with wages, bonuses and benefits instead of the
distributor allowances and royalty overrides utilized in our
traditional marketing program used in our other five regions.
Because of local country regulatory constraints, we may be
required to modify our typical distributor incentive plans as
described above. Consequently, the total distributor discount
percentage may vary over time. We also offer reduced distributor
allowances and pay reduced royalty overrides with respect to
certain products worldwide.
Our operating margins consist of net sales
less cost of sales and royalty overrides.
Selling, general and administrative expenses
represent our operating expenses, components of which
include labor and benefits, sales events, professional fees,
travel and entertainment, distributor marketing, occupancy
costs, communication costs, bank fees, depreciation and
amortization, foreign exchange gains and losses and other
miscellaneous operating expenses.
Most of our sales to distributors outside the United States are
made in the respective local currencies. In preparing our
financial statements, we translate revenues into
U.S. dollars using average exchange rates. Additionally,
the majority of our purchases from our suppliers generally are
made in U.S. dollars. Consequently, a strengthening of the
U.S. dollar versus a foreign currency can have a negative
impact on our reported sales and operating margins and can
generate transaction losses on intercompany transactions.
Throughout the last five years, foreign currency exchange rates
have fluctuated significantly. From time to time, we enter into
foreign exchange forward and option contracts to mitigate our
foreign currency exchange risk as discussed in further detail in
Part I, Item 3 Quantitative and
Qualitative Disclosures about Market Risk.
Summary
Financial Results
Net sales for the three months ended March 31, 2009
decreased 13.7% to $521.7 million compared to the same
period in 2008, primarily reflecting the adverse effect of
currency fluctuations which had an adverse impact of 12.8% or
$77.2 million. In local currency, net sales declined 0.9%
compared to the same period in 2008. For the three months ended
March 31, 2009 net sales in some of our top countries
including Mexico, Venezuela, Japan and
20
Brazil decreased 36.8%, 30.7%, 28.0% and 7.6%, respectively, as
compared to the same period in 2008, while other top countries
including Taiwan, the U.S. and China increased 41.7%, 4.5%
and 9.4%, respectively, as compared to the same period in 2008.
A decline in distributor and sales leader recruiting and the
negative impact of the Value Added Tax, or VAT, in Mexico and
2008 price increases in Venezuela also contributed to the
decline in net sales for the period. The increase in other top
markets was mainly due to the continued success of our
distributors as they continued their conversion to a daily
consumption business model and an increase in the number of
sales employees in China compared to the prior year period.
Net income for the three months ended March 31, 2009
decreased 33.4% to $41.5 million, or $0.67 per diluted
share, compared to $62.4 million, or $0.93 per diluted
share, for the same period in 2008. The decrease was driven by
revenue declines, higher effective tax rate reflecting changes
in country mix, higher depreciation expense and foreign currency
losses, partially offset by lower interest expense, lower labor
costs resulting from our restructuring initiative and lower
sales events costs. Net income for the three months ended
March 31, 2009 included a $0.4 million unfavorable
after tax impact in connection with our restructuring activities.
Results
of Operations
Our results of operations for the periods described below are
not necessarily indicative of results of operations for future
periods, which depend upon numerous factors, including our
ability to recruit new distributors and retain existing
distributors, open new markets, further penetrate existing
markets, introduce new products and programs that will help our
distributors increase their retail efforts and develop niche
market segments.
The following table sets forth selected results of our
operations expressed as a percentage of net sales for the
periods indicated.
|
|
|
|
|
|
|
|
|
|
|
Three Months
|
|
|
Three Months
|
|
|
|
Ended
|
|
|
Ended
|
|
|
|
March 31, 2009
|
|
|
March 31, 2008
|
|
|
Operations:
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
Cost of sales
|
|
|
19.6
|
|
|
|
19.5
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
80.4
|
|
|
|
80.5
|
|
Royalty overrides(1)
|
|
|
33.7
|
|
|
|
35.2
|
|
Selling, general and administrative expenses(1)
|
|
|
34.8
|
|
|
|
30.5
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
11.9
|
|
|
|
14.8
|
|
Interest expense, net
|
|
|
0.3
|
|
|
|
0.6
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
11.6
|
|
|
|
14.2
|
|
Income taxes
|
|
|
3.6
|
|
|
|
3.9
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
8.0
|
%
|
|
|
10.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Compensation to our China sales employees is included in
selling, general and administrative expenses while distributor
compensation for all other countries is included in royalty
overrides. |
21
Net
Sales
The following chart reconciles retail sales to net sales:
Sales by
Geographic Region
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
Handling
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handling
|
|
|
|
|
|
Change
|
|
|
|
Retail
|
|
|
Distributor
|
|
|
Product
|
|
|
& Freight
|
|
|
Net
|
|
|
Retail
|
|
|
Distributor
|
|
|
Product
|
|
|
& Freight
|
|
|
Net
|
|
|
in Net
|
|
|
|
Sales
|
|
|
Allowance
|
|
|
Sales
|
|
|
Income
|
|
|
Sales
|
|
|
Sales
|
|
|
Allowance
|
|
|
Sales
|
|
|
Income
|
|
|
Sales
|
|
|
Sales
|
|
|
|
(Dollars in millions)
|
|
|
North America
|
|
$
|
196.6
|
|
|
$
|
(93.7
|
)
|
|
$
|
102.9
|
|
|
$
|
20.2
|
|
|
$
|
123.1
|
|
|
$
|
189.5
|
|
|
$
|
(90.2
|
)
|
|
$
|
99.3
|
|
|
$
|
19.3
|
|
|
$
|
118.6
|
|
|
|
3.8
|
%
|
Mexico
|
|
|
97.8
|
|
|
|
(47.7
|
)
|
|
|
50.1
|
|
|
|
9.1
|
|
|
|
59.2
|
|
|
|
156.7
|
|
|
|
(76.5
|
)
|
|
|
80.2
|
|
|
|
13.4
|
|
|
|
93.6
|
|
|
|
(36.8
|
)%
|
South and Central America
|
|
|
124.3
|
|
|
|
(59.9
|
)
|
|
|
64.4
|
|
|
|
10.9
|
|
|
|
75.3
|
|
|
|
191.7
|
|
|
|
(98.7
|
)
|
|
|
93.0
|
|
|
|
13.0
|
|
|
|
106.0
|
|
|
|
(29.0
|
)%
|
EMEA
|
|
|
199.9
|
|
|
|
(96.8
|
)
|
|
|
103.1
|
|
|
|
20.2
|
|
|
|
123.3
|
|
|
|
257.0
|
|
|
|
(124.2
|
)
|
|
|
132.8
|
|
|
|
25.2
|
|
|
|
158.0
|
|
|
|
(22.0
|
)%
|
Asia Pacific
|
|
|
189.3
|
|
|
|
(89.7
|
)
|
|
|
99.6
|
|
|
|
14.4
|
|
|
|
114.0
|
|
|
|
171.7
|
|
|
|
(80.8
|
)
|
|
|
90.9
|
|
|
|
12.8
|
|
|
|
103.7
|
|
|
|
9.9
|
%
|
China
|
|
|
29.0
|
|
|
|
(2.2
|
)
|
|
|
26.8
|
|
|
|
|
|
|
|
26.8
|
|
|
|
27.2
|
|
|
|
(2.7
|
)
|
|
|
24.5
|
|
|
|
|
|
|
|
24.5
|
|
|
|
9.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Worldwide
|
|
$
|
836.9
|
|
|
$
|
(390.0
|
)
|
|
$
|
446.9
|
|
|
$
|
74.8
|
|
|
$
|
521.7
|
|
|
$
|
993.8
|
|
|
$
|
(473.1
|
)
|
|
$
|
520.7
|
|
|
$
|
83.7
|
|
|
$
|
604.4
|
|
|
|
(13.7
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in net sales are directly associated with the recruiting
and retention of our distributor force, retailing of our
products, the quality and completeness of our product offerings
that the distributor force has to sell and the number of
countries in which we operate. Managements role, both
in-country and at the corporate level is to provide distributors
with a competitive and broad product line, encourage strong
teamwork and leadership among the Chairmans Club and
Presidents Team distributors and offer leading edge
business tools to make doing business with Herbalife simple.
Management uses the distributor marketing program coupled with
educational and motivational tools and promotions to incentivize
distributors to increase recruiting, retention and retailing,
which in turn affect net sales. Such tools include Company
sponsored sales events such as Extravaganzas and World Team
Schools where large groups of distributors gather, thus allowing
them to network with other distributors, learn recruiting,
retention and retailing techniques from our leading distributors
and become more familiar with how to market and sell our
products and business opportunities. Accordingly, management
believes that these development and motivation programs increase
the productivity of the supervisor network. The expenses for
such programs are included in selling, general and
administrative expenses. Sales are driven by several factors,
including the number and productivity of distributors and sales
leaders who continually build, educate and motivate their
respective distribution and sales organizations. We also use
event and non-event product promotions to motivate distributors
to increase recruiting, retention and retailing activities.
These promotions have prizes ranging from qualifying for events
to product prizes and vacations. The costs of these promotions
are included in selling, general and administrative expenses.
The factors described above have helped distributors increase
their business, which in turn helps drive sales in our business.
The discussion below of net sales by geographic region further
details some of the specific drivers of growth of our business
and causes of sales reductions during the three months ended
March 31, 2009, as well as the unique growth or contraction
factors specific to certain geographic regions or major
countries. We believe that the correct business foundation,
coupled with ongoing training and promotional initiatives, is
required to increase recruiting and retention of distributors
and retailing our products. The correct business foundation
includes strong country management that works closely with the
distributor leadership, unified distributor leadership, a broad
product line that appeals to local consumer needs, a favorable
regulatory environment, a scalable and stable technology
platform and an attractive distributor marketing plan.
Initiatives, such as Success Training Seminars, World Team
Schools, Promotional Events and regional Extravaganzas are
integral components of developing a highly motivated and
educated distributor sales organization that will work toward
increasing the recruitment and retention of distributors.
Our strategy will continue to include creating and maintaining
growth within existing markets, while expanding into new
markets. In addition, new ideas and Daily Method of Operations,
or DMOs, are being generated in our regional markets and
globalized where applicable, either by distributors, country
management or
22
corporate management. Examples of DMOs include the Club concept
in Mexico, the Total Plan in Brazil, the Wellness Coach in
France, and the Internet/Sampling and Weight Loss Challenge in
the U.S. Managements strategy is to review the
applicability of expanding successful country initiatives
throughout a region, and where appropriate, financially support
the globalization of these initiatives.
North
America
The North America region reported net sales of
$123.1 million for the three months ended March 31,
2009. Net sales increased $4.5 million, or 3.8%, for the
three months ended March 31, 2009, as compared to the same
period in 2008. In local currency, net sales increased by 4.4%
for the three months ended March 31, 2009, as compared to
the same period in 2008. The overall increase was a result of
net sales growth in the U.S. of $5.1 million, or 4.5%,
for the three months ended March 31, 2009, as compared to
the same period in 2008.
The increase in net sales in North America was primarily due to
the continued success of our distributors converting their
business focus toward a daily consumption business model,
especially the Nutrition Club DMO, and its extension into
Commercial Clubs and Central Clubs, along with the recent
development of the Weight Loss Challenge DMO. In terms of
volume, the mix of business in the U.S. was 63% Spanish
speaking and 37% Non-Spanish speaking for the three months ended
March 31, 2009.
In January 2009, the U.S. hosted a Why Herbalife, Why
Now? tour in seven cities featuring our Chief Executive
Officer, or CEO, Michael O. Johnson. In total over 14,500
distributors attended the tour.
New supervisors in the region decreased 12.4% for the three
months ended Mach 31, 2009, as compared to the same period in
2008. Total supervisors in the region decreased 1.0%. New
supervisors in the U.S. decreased 12.6% for the three
months ended March 31, 2009, as compared to the same period
in 2008.
In March 2009, Herbalife hosted its annual global Herbalife
Honors event in Los Angeles, where President Team members from
around the world met and shared best practices, conducted
leadership training and Herbalife management awarded
distributors $36.4 million in Mark Hughes bonus payments
related to 2008 performance.
We believe the fiscal year 2009 net sales in North America
should increase year over year primarily as a result of the
successful transformation of our distributor business focus to a
daily consumption model as well as a 5% price increase which was
instituted in the U.S. during February 2009.
Mexico
Net sales in Mexico were $59.2 million for the three months
ended March 31, 2009. Net sales for the three months ended
March 31, 2009 decreased $34.4 million, or 36.8%, as
compared to the same period in 2008. In local currency, net
sales for the three months ended March 31, 2009 decreased
by 15.9%, as compared to the same period in 2008. The
fluctuation of foreign currency rates had an unfavorable impact
of $19.4 million on net sales for the three months ended
March 31, 2009.
During the third quarter of 2008 we began collecting a VAT from
our distributors that has been levied by the Mexican government
on the import and resale of certain nutrition products.
Distributors previously paid 0% VAT on purchases of most of our
nutrition products. In the first quarter of 2009, this VAT
increase affected approximately 56% of our sales volume in the
region and because Nutrition Clubs are the predominant DMO in
Mexico, which are retail price-sensitive, the VAT increase has
caused our volumes to decline. We are in the process of
challenging this assessment on several fronts, however in the
near-term while the products continue to be subject to VAT, we
expect volume growth to be constrained in Mexico. We are also
exploring product re-formulations that would enable us to sell
nutrition products in Mexico which would not be subject to the
VAT charge.
New supervisors in Mexico decreased 40.8% for the year ended
March 31, 2009, as compared to the same period in 2008.
Total supervisors in Mexico decreased 17.6%.
In January 2009, Mexico hosted a Presidents Tour in
15 cities which was attended by over 16,000 distributors.
In March 2009, Mexico hosted a Why Herbalife, Why
Now? tour in four cities featuring CEO Michael O. Johnson
with a combined total attendance of over 16,000 distributors.
23
We believe the fiscal year 2009 net sales in Mexico should
decrease reflecting lower volumes due to the VAT charge coupled
with assumed unfavorable currency fluctuations.
South
and Central America
The South and Central America region reported net sales of
$75.3 million for the three months ended March 31,
2009. Net sales decreased $30.7 million or 29.0% for the
three months ended March 31, 2009, as compared to the same
period in 2008. In local currency, net sales decreased 16.5% for
the three months ended March 31, 2009, as compared to the
same period in 2008. The fluctuation of foreign currency rates
had a $13.3 million unfavorable impact on net sales for the
three months ended March 31, 2009. The decrease in local
currency net sales in the region was attributable to net sales
decreases in most of the markets in the region partially offset
by sales in Ecuador which was opened in the fourth quarter of
2008.
In Brazil, the regions largest market, net sales decreased
$2.7 million, or 7.6%, for the three months ended
March 31, 2009, as compared to the same period in 2008. In
local currency, net sales increased 23.0% for the three months
ended March 31, 2009, as compared to the same period in
2008. The increase in local currency net sales was a result of
distributors successfully transforming this market into a more
balanced mix of recruiting, retailing and retention via the
Nutrition Club and daily consumption based DMOs. The fluctuation
of foreign currency rates had a $10.9 million unfavorable
impact on net sales for the three months ended March 31,
2009.
Venezuela, the regions second largest market, experienced
a net sales decrease of $7.7 million or 30.7%, for the
three months ended March 31, 2009 as compared to the same
period in 2008. On a sequential quarter basis, Venezuela appears
to have stabilized following a slowdown in volume during the
second half of 2008 as a result of price increases of 20% and
25% in January and May 2008, respectively.
In February 2009, the region hosted three Extravaganzas in
Chile, Colombia, and Panama with collectively over 18,300
distributors in attendance. In addition, Brazil hosted an
Extravaganza in April 2009 with attendance of over 12,000
distributors.
New supervisors in the region decreased 39.6% for the three
months ended March 31, 2009, as compared to the same period
in 2008. For the three months ended March 31, 2009, the
decrease was driven by declines in Argentina, Venezuela, Bolivia
and Peru of 84.3%, 72.1%, 59.8%, and 57.5%, respectively, as
compared to the same period in 2008. These declines were
partially offset by increases in new supervisor growth in Brazil
which increased 11.8% for the three months ended March 31,
2009 as compared to the same period in 2008. Total supervisors
in the region decreased 1.9%.
We believe the fiscal year 2009 net sales in South and
Central America should show a decline primarily due to
challenging volume comparisons in Venezuela, Argentina and Peru
and assumed unfavorable currency fluctuations partially offset
by the success of daily consumption DMOs, primarily in Brazil,
as well as product price increases.
EMEA
The EMEA region reported net sales of $123.3 million for
the three months ended March 31, 2009. Net sales decreased
$34.7 million, or 22.0%, for the three months ended
March 31, 2009, as compared to 2008. In local currency, net
sales decreased 6.6% for the three months ended March 31,
2009, as compared to 2008. The fluctuation of foreign currency
rates had an unfavorable impact on net sales of
$24.3 million for the three months ended March 31,
2009.
Among the largest markets in the region, Italy, France and Spain
net sales decreased 3.9%, 22.5% and 48.3%, respectively, for the
three months ended March 31, 2009, as compared to the same
period in 2008. In local currency, Italy reported a net sales
increase of 10.5% while France and Spain reported net sales
decreases of 10.8% and 40.8%, respectively, for the three months
ended March 31, 2009, as compared to the same period in
2008. The decrease in net sales for Spain reflects the impact of
negative media reports in April 2008 relating to the Spanish
Ministry of Health alert regarding Herbalife products. In
Russia, net sales decreased by 21.0% for the three months ended
March 31, 2009, as compared to the same period in 2008. In
local currency, however, net sales increased by 11.6% for the
three months ended March 31, 2009, as compared to the same
period in 2008. The increase in local currency net sales was
primarily driven by the continued adoption of the Nutrition Club
concept in the form of a
24
Breakfast Club DMO. Net sales in the Netherlands decreased 11.9%
for the three months ended March 31, 2009, as compared to
the same period in 2008. In local currency, however, net sales
increased 1.1% over the same period compared to the prior year
period reflecting a re-activated distributor base that is
utilizing the Wellness Evaluation and Healthy Breakfast DMOs.
Portugal net sales declined 61.8% for the three months ended
March 31, 2009, as it continues to transition towards a
daily consumption model.
For the three months ended March 31, 2009, new supervisors
for the region decreased 19.9%, with declines in Portugal, Spain
and the CIS countries of 78.7%, 62.6% and 35.4%, respectively.
These declines were partially offset by increases in Russia and
Italy, where new supervisors increased 26.4% and 10.5%,
respectively, for the three months ended March 31, 2009.
Total supervisors in the region decreased 10.3%.
We believe fiscal year 2009 net sales in EMEA should show a
decrease due primarily to assumed unfavorable currency
fluctuations and soft volume point trends.
Asia
Pacific
The Asia Pacific region, which excludes China, reported net
sales of $114.0 million for the three months ended
March 31, 2009. Net sales increased $10.3 million, or
9.9%, for the three months ended March 31, 2009, as
compared to the same period in 2008. In local currency, net
sales increased 29.8% for the three months ended March 31,
2009, as compared to the same period in 2008. The fluctuation of
foreign currency rates had an unfavorable impact of
$20.6 million on net sales for the three months ended
March 31, 2009. The increase in net sales in Asia Pacific
was primarily attributable to increases in three of our largest
markets in the region, Taiwan, South Korea and Malaysia,
partially offset by a decrease in Japan.
Net sales in Taiwan, our largest market in the region, increased
$12.7 million, or 41.7%, for the three months ended
March 31, 2009, as compared to the same period in 2008. In
local currency, net sales increased 54.3% for the three months
ended March 31, 2009, as compared to the same period in
2008. Adoption of the Nutrition Club DMO, in the form of
Commercial Clubs, has been a positive catalyst for growth in
this country. Sales were further bolstered in the first quarter
of 2009 by a promotion which was done in conjunction with a
government sponsored Consumption Voucher project. This promotion
was in place for both February and March.
Net sales in South Korea, our second largest market in the
region, increased $0.8 million, or 5.0%, for the three
months ended March 31, 2009, as compared to the same period
in 2008. In local currency, net sales increased 55.9% for the
three months ended March 31, 2009, as compared to the same
period in 2008. The increase in local currency net sales was
driven by branding activities and the adoption of the Nutrition
Club DMO, in the form of Commercial Clubs. The fluctuation of
foreign currency rates had an unfavorable impact on net sales of
$8.3 million or 50.9% for the three months ended
March 31, 2009, as compared to the same period in 2008.
Net sales in Japan, our third largest market in the region,
decreased $6.0 million, or 28.0%, for the three months
ended March 31, 2009, as compared to the same period in
2008. In local currency, net sales decreased 18.0% for the three
months ended March 31, 2009, as compared to the same period
in 2008. The decrease in local currency net sales was driven by
a continuing decline in distributor recruiting. The fluctuation
of foreign currency rates had an unfavorable impact on net sales
of $2.1 million or 10.0% for the three months ended
March 31, 2009, as compared to the same period in 2008.
Net sales in Malaysia, our fourth largest market in the region,
increased $2.9 million, or 34.7%, for the three months
ended March 31, 2009, as compared to the same period in
2008, reflecting the continued success of the Road Show DMO,
which has generated positive distributor momentum and increased
recruiting. In local currency, net sales increased 51.6% for the
three months ended March 31, 2009, as compared to the same
period in 2008.
New supervisors in the region increased 22.3% for the three
months ended March 31, 2009, as compared to the same period
in 2008. New supervisors for India, Korea and Taiwan increased
83.8%, 56.4% and 29.2%, respectively, for the three months ended
March 31, 2009. These increases were offset by declines in
Japan and Australia of 71.5% and 39.7%, respectively, for the
three months ended March 31, 2009. Total supervisor growth
in the region increased 7.0%.
25
We believe the fiscal year 2009 net sales in Asia Pacific
should be approximately flat compared to prior year as projected
volume increases will be offset by assumed unfavorable foreign
currency fluctuations.
China
Net sales in China were $26.8 million for the three months
ended March 31, 2009. Net sales increased
$2.3 million, or 9.4%, for three months ended
March 31, 2009, compared to the same period in 2008. In
local currency, net sales increased 4.8% for the three months
ended March 31, 2009, as compared to the same period in
2008. The fluctuation of foreign currency rates had a favorable
impact of $1.2 million on net sales for the three months
ended March 31, 2009.
The current focus in China is to transition to a more retail
based environment led by the introduction of nutrition clubs to
increase the emphasis on daily consumption methods of operation.
As experienced in other markets which have gone through a
similar transition, China is experiencing a slow-down in sales
growth as distributors begin to build their nutrition club
business. As of March 31, 2009, there were currently over
100 clubs operating within major cities throughout China. We
believe the recent success of the club DMO in Taiwan could be
achieved over the next few years throughout China.
In March 2009, China held a Spectacular in the city of Nanjing
with over 9,000 attendees.
As of March 31, 2009, we had 84 stores in China across 30
provinces. We currently have direct selling licenses in six
provinces: JiangSu, Beijing, Guangdong, Shandong, Zhejiang
(excluding Ningbo) and Guizhou. In Beijing, our direct selling
license will permit us to sell away from fixed retail locations
once our Beijing outlet is inspected and confirmed by the
relevant authority. In addition, we have submitted applications
for five additional direct selling licenses in China.
New sales employees in China decreased 0.5% for the three months
ended March 31, 2009, as compared to the same period in
2008. Overall, sales employees in China increased 17.2%.
We believe the fiscal year 2009 net sales in China should
increase slightly year over year, primarily as a result of
improved store productivity and continuing growth of nutrition
clubs.
Sales by
Product Category
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
Handling
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handling
|
|
|
|
|
|
|
|
|
|
Retail
|
|
|
Distributor
|
|
|
Product
|
|
|
& Freight
|
|
|
Net
|
|
|
Retail
|
|
|
Distributor
|
|
|
Product
|
|
|
& Freight
|
|
|
Net
|
|
|
% Change in
|
|
|
|
Sales
|
|
|
Allowance
|
|
|
Sales
|
|
|
Income
|
|
|
Sales
|
|
|
Sales
|
|
|
Allowance
|
|
|
Sales
|
|
|
Income
|
|
|
Sales
|
|
|
Net Sales
|
|
|
|
(In millions)
|
|
|
Weight Management
|
|
$
|
542.8
|
|
|
$
|
(262.1
|
)
|
|
$
|
280.7
|
|
|
$
|
48.5
|
|
|
$
|
329.2
|
|
|
$
|
644.3
|
|
|
$
|
(317.8
|
)
|
|
$
|
326.5
|
|
|
$
|
54.3
|
|
|
$
|
380.8
|
|
|
|
(13.6
|
)%
|
Targeted Nutrition
|
|
|
181.4
|
|
|
|
(87.6
|
)
|
|
|
93.8
|
|
|
|
16.2
|
|
|
|
110.0
|
|
|
|
212.6
|
|
|
|
(104.9
|
)
|
|
|
107.7
|
|
|
|
17.9
|
|
|
|
125.6
|
|
|
|
(12.4
|
)%
|
Energy, Sports and Fitness
|
|
|
35.5
|
|
|
|
(17.1
|
)
|
|
|
18.4
|
|
|
|
3.2
|
|
|
|
21.6
|
|
|
|
40.6
|
|
|
|
(20.0
|
)
|
|
|
20.6
|
|
|
|
3.4
|
|
|
|
24.0
|
|
|
|
(10.0
|
)%
|
Outer Nutrition
|
|
|
52.0
|
|
|
|
(25.1
|
)
|
|
|
26.9
|
|
|
|
4.6
|
|
|
|
31.5
|
|
|
|
68.1
|
|
|
|
(33.6
|
)
|
|
|
34.5
|
|
|
|
5.7
|
|
|
|
40.2
|
|
|
|
(21.6
|
)%
|
Literature, Promotional and Other
|
|
|
25.2
|
|
|
|
1.9
|
|
|
|
27.1
|
|
|
|
2.3
|
|
|
|
29.4
|
|
|
|
28.2
|
|
|
|
3.2
|
|
|
|
31.4
|
|
|
|
2.4
|
|
|
|
33.8
|
|
|
|
(13.0
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
836.9
|
|
|
$
|
(390.0
|
)
|
|
$
|
446.9
|
|
|
$
|
74.8
|
|
|
$
|
521.7
|
|
|
$
|
993.8
|
|
|
$
|
(473.1
|
)
|
|
$
|
520.7
|
|
|
$
|
83.7
|
|
|
$
|
604.4
|
|
|
|
(13.7
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales of all product categories decreased for the three
months ended March 31, 2009, as compared to the same period
in 2008, mainly due to the changes in net sales in the
geographic regions discussed above.
Gross
Profit
Gross profit was $419.3 million for the three months ended
March 31, 2009, as compared to $486.8 million for the
same period in 2008. As a percentage of net sales, gross profit
for the three months ended March 31, 2009 decreased
slightly to 80.4% as compared to 80.5% for the same period in
2008. Generally, gross profit percentages do not vary
significantly as a percentage of net sales. We are experiencing
ingredient and product price pressure in
26
the areas of soy and dairy products along with currency
fluctuations reflecting current global economic trends. We
believe that we have the ability to mitigate some of these cost
increases through improved optimization of our supply chain
coupled with select increases in the retail prices of our
products.
Royalty
Overrides
Royalty overrides as a percentage of net sales was 33.7% for the
three months ended March 31, 2009, as compared to 35.2% for
the same period in 2008. The decrease for the three months ended
March 31, 2009, was primarily due to changes in country mix
and the increase in net sales in China where compensation to our
full-time employee sales representatives is included in selling,
general and administrative expenses as opposed to royalty
overrides where it is included for all other distributors under
our worldwide marketing plan. Generally, this ratio varies
slightly from period to period due to changes in the mix of
products and countries because full royalty overrides are not
paid on certain products and in certain countries. We anticipate
fluctuations in royalty overrides as a percent of net sales
reflecting the growth prospect of our China business relative to
that of our worldwide business.
Selling,
General and Administrative Expenses
Selling, general and administrative expenses as a percentage of
net sales was 34.8% for the three months ended March 31,
2009, as compared to 30.5% for the same period in 2008.
For the three months ended March 31, 2009, selling, general
and administrative expenses decreased $2.9 million to
$181.5 million from $184.4 million for the same period
in 2008. The decrease for the three months ended March 31,
2009 included $1.7 million in lower salaries and benefits
mainly resulting from our restructuring initiatives;
$4.3 million in lower distributor sales events costs; and
$4.1 million in lower non-income tax expenses. These
decreases were partially offset by $4.5 million in higher
depreciation and amortization expenses, related mostly to the
development of our technology infrastructure and the expansion
and relocation of certain of our operations to new facilities;
and $3.9 million in higher foreign currency exchange losses
during the three months ended March 31, 2009 as compared to
the same period in 2008.
We expect 2009 selling, general and administrative expenses to
increase slightly in absolute dollars over 2008 levels
reflecting higher China sales employee costs, increased
depreciation, primarily related to our global Oracle
implementation, and various sales growth initiatives, including
distributor promotions. As a result of these factors, selling,
general and administrative expenses as a percentage of net sales
is expected to be above 2008 levels. Excluding China sales
employee costs, we also expect selling, general and
administrative expenses as a percentage of net sales to be
higher than 2008 levels.
Net
Interest Expense
Net interest expense is as follows:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
Net Interest Expense
|
|
2009
|
|
|
2008
|
|
|
|
(Dollars in millions)
|
|
|
Interest expense
|
|
|
3.3
|
|
|
|
5.5
|
|
Interest income
|
|
|
(1.6
|
)
|
|
|
(1.7
|
)
|
|
|
|
|
|
|
|
|
|
Net interest expense
|
|
$
|
1.7
|
|
|
$
|
3.8
|
|
|
|
|
|
|
|
|
|
|
The decrease in interest expense for the three months ended
March 31, 2009 as compared to the same period in 2008 was
primarily due to lower interest rates in 2009 as compared to
2008. See Liquidity and Capital Resources
below for further discussion on our senior secured credit
facility.
Income
Taxes
Income taxes were $19.0 million for the three months ended
March 31, 2009, as compared to $23.5 million for the
same period in 2008. As a percentage of pre-tax income, the
effective income tax rate was 31.4% for the three months ended
March 31, 2009, as compared to 27.4% for the same period in
2008. The increase in the effective tax
27
rate for the three months ended March 31, 2009, as compared
to the same period in 2008, was primarily due to an increase in
the operating effective tax rate reflecting changes in the
country mix.
Restructuring
Costs
As part of our restructuring initiatives, we recorded
$0.6 million and $0.4 million of professional fees,
severance and related costs for the three months ended
March 31, 2009 and 2008, respectively. All such amounts
were included in selling, general and administrative expenses.
Subsequent
Event
On April 30, 2009, our board of directors authorized a
$0.20 per common share cash dividend for the first quarter of
2009, payable on June 5, 2009 to shareholders of record on
May 22, 2009.
Our share repurchase program in effect on March 31, 2009
expired on April 17, 2009 pursuant to its terms. On
April 30, 2009, we announced that our board of directors
authorized a new program to repurchase up to $300 million
of our common shares during the next two years, at such times
and prices as determined by management.
Liquidity
and Capital Resources
We have historically met our working capital and capital
expenditure requirements, including funding for expansion of
operations, through net cash flows provided by operating
activities. Our principal source of liquidity is our operating
cash flows. Variations in sales of our products would directly
affect the availability of funds. There are no material
restrictions on the ability to transfer and remit funds among
our international affiliated companies. We are closely
monitoring various aspects of the current worldwide financial
crisis and we do not believe that there has been or will be a
material impact on our liquidity from this crisis. As noted
above, we have historically met our funding needs utilizing cash
flow from operating activities and we believe we will have
sufficient resources to meet debt service obligations in a
timely manner. Our existing debt has primarily resulted from our
share repurchase activities and not from the need to fund our
normal operations, therefore limiting the impact that the
current worldwide credit crisis has on us. While a significant
net sales decline could potentially affect the availability of
funds, many of our largest expenses are purely variable in
nature, which could protect our funding in all but a dramatic
net sales downturn. Further we maintain a revolving credit
facility which had $68.0 million of undrawn capacity as of
March 31, 2009, and is comprised of banks who are
continuing to support the facility through the recent worldwide
financial crisis.
For the three months ended March 31, 2009, we generated
$86.0 million of operating cash flow, as compared to
$62.8 million for the same period in 2008. The increase in
cash generated from operations was primarily due to the increase
in non-cash items included in net income for the three months
ended March 31, 2009, as compared to the same period in
2008, and decrease in operating assets for the three months
ended March 31, 2009, compared to an increase in operating
assets and liabilities for the same period in 2008. This was
partially offset by lower operating income for the three months
ended March 31, 2009, compared to the same period in 2008.
Capital expenditures, including capital leases, for the three
months ended March 31, 2009, were $14.4 million as
compared to $24.6 million for the same period in 2008. The
majority of these expenditures represented investments in
management information systems, the development of our
distributor internet initiatives, and the expansion of our
facilities domestically and internationally. The decrease from
2008 was primarily related to the Oracle upgrade and
implementation in certain regions. We expect to incur capital
expenditures of approximately $60.0 million in 2009.
We entered into a $300.0 million senior secured credit
facility, comprised of a $200.0 million term loan and a
revolving credit facility of $100.0 million, with a
syndicate of financial institutions as lenders in July 2006. The
term loan matures on July 21, 2013 and the revolving credit
facility is available until July 21, 2012. The term loan
bears interest at LIBOR plus a margin of 1.5%, or the base rate,
which represents the prime rate offered by major
U.S. banks, plus a margin of 0.50%. The revolving credit
facility bears interest at LIBOR plus a margin of 1.25%, or the
base rate, which represents the prime rate offered by major
U.S. banks, plus a margin of 0.25%. In September 2007, we
amended our senior secured credit facility, increasing the
revolving credit facility by $150.0 million to
28
$250.0 million to fund the increase in our share repurchase
program discussed below. During the first quarter of 2009, the
Company borrowed an additional $19.0 million under the
revolving credit facility and paid $14.7 million of the
revolving credit facility.
The following summarizes our contractual obligations including
interest at March 31, 2009, and the effect such obligations
are expected to have on our liquidity and cash flows in future
periods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2014 &
|
|
|
|
Total
|
|
|
2009
|
|
|
2010
|
|
|
2011
|
|
|
2012
|
|
|
2013
|
|
|
Thereafter
|
|
|
|
(Dollars in millions)
|
|
|
Borrowings under the senior credit facility
|
|
$
|
356.4
|
|
|
$
|
6.6
|
|
|
$
|
8.8
|
|
|
$
|
8.7
|
|
|
$
|
189.3
|
|
|
$
|
143.0
|
|
|
$
|
|
|
Capital leases
|
|
|
6.8
|
|
|
|
1.9
|
|
|
|
2.1
|
|
|
|
1.8
|
|
|
|
1.0
|
|
|
|
|
|
|
|
|
|
Operating leases
|
|
|
141.3
|
|
|
|
25.3
|
|
|
|
26.8
|
|
|
|
19.2
|
|
|
|
14.7
|
|
|
|
14.0
|
|
|
|
41.3
|
|
Other
|
|
|
26.8
|
|
|
|
6.6
|
|
|
|
14.9
|
|
|
|
5.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
531.3
|
|
|
$
|
40.4
|
|
|
$
|
52.6
|
|
|
$
|
35.0
|
|
|
$
|
205.0
|
|
|
$
|
157.0
|
|
|
$
|
41.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Off
Balance Sheet Arrangements
At March 31, 2009 and December 31, 2008, we had no
material off-balance sheet arrangements as defined in
Item 303(a)(4)(ii) of
Regulation S-K.
Share
Repurchases
On April 18, 2007, our board of directors authorized the
repurchase of up to $300 million of our common shares
during the next two years, at such times and prices as
determined by our management, as market conditions warrant. On
August 23, 2007, our board of directors approved an
increase of $150 million, raising the total value of our
common shares authorized to be repurchased to $450 million.
On May 20, 2008, our board of directors approved an
additional increase of $150 million to our previously
authorized share repurchase program raising the total value of
common shares authorized to be repurchased to $600 million.
During the three months ended March 31, 2009, we did not
repurchase any of our common shares. As of March 31, 2009,
since the inception of the share repurchase program, we have
repurchased approximately 13.7 million of our common shares
at an aggregate cost of $502.8 million, or an average cost
of $36.76 per share. As of March 31, 2009, approximately
$97.2 million of this authorization remained available.
This share repurchase program expired on April 17, 2009
pursuant to its terms.
Dividends
During the second quarter of 2007, our board of directors
adopted a regular quarterly cash dividend program. On
February 20, 2009, our board of directors approved a
quarterly cash dividend of $0.20 per common share in an
aggregate amount of $12.3 million, for the fourth quarter
of 2008 that was paid to shareholders of record on
March 17, 2009.
Working
Capital and Operating Activities
As of March 31, 2009 and December 31, 2008, we had
positive working capital of $114.4 million and
$82.9 million, respectively. Cash and cash equivalents were
$194.7 million at March 31, 2009, compared to
$150.8 million at December 31, 2008.
We expect that cash and funds provided from operations and
available borrowings under our revolving credit facility will
provide sufficient working capital to operate our business, to
make expected capital expenditures and to meet foreseeable
liquidity requirements, including debt service on our term loan.
The majority of our purchases from suppliers are generally made
in U.S. dollars, while sales to our distributors generally
are made in local currencies. Consequently, strengthening of the
U.S. dollar versus a foreign currency can have a negative
impact on net sales and operating margins and can generate
transaction losses on intercompany
29
transactions. For discussion of our foreign exchange contracts
and other hedging arrangements, see Part I, Item 3
Quantitative and Qualitative Disclosures about
Market Risk.
Currency restrictions enacted by the Venezuelan government in
2003 have become more restrictive and have impacted the ability
of our Venezuelan subsidiary, Herbalife Venezuela, to obtain
U.S. dollars at the official foreign exchange rate. Unless
official foreign exchange is made more readily available, the
results of Herbalife Venezuelas operations could be
negatively impacted as it may obtain more U.S. dollars from
alternative sources where the exchange rate is weaker than the
official rate.
At March 31, 2009, Herbalife Venezuela had cash balances of
approximately $43.9 million, primarily denominated in
bolivars, translated at the official exchange rate. We continue
to evaluate the political and economic environment in Venezuela
and any potential changes which may affect our operations. We
continue to make appropriate applications through the Venezuelan
government and its Foreign Exchange Commission, CADIVI, for
approval to obtain U.S. dollars at the official exchange
rate to pay for imported product and to pay an annual dividend.
The approval process has been delayed in recent periods and we
have not been given any assurances as to when it will be
completed. Herbalife Venezuela may rely on a legal parallel
exchange process to repatriate U.S. dollars and we would
currently be able to do so at an unfavorable exchange rate. This
could result in our Company having fewer U.S. dollars than
currently reported as cash and cash equivalents and may result
in a charge to operating profit. From time to time, we have
recognized charges to operating income in connection with the
exchange of bolivars to U.S. dollars at rates which were
unfavorable to the official exchange rate. Herbalife
Venezuelas net sales represented less than 4% of
consolidated worldwide net sales for the three months ended
March 31, 2009.
Inflation in Venezuela has continued to increase over the past
few years and it is possible that Venezuela will be designated
as a highly inflationary economy during 2009. Gains and losses
resulting from the translation of the financial statements of
subsidiaries operating in highly inflationary economies are
recorded in earnings. If Venezuela is designated as a highly
inflationary economy and there is a devaluation of the official
rate, earnings could be negatively impacted.
Contingencies
We are from time to time engaged in routine litigation. We
regularly review all pending litigation matters in which we are
involved and establish reserves deemed appropriate by management
for these litigation matters when a probable loss estimate can
be made.
As a marketer of dietary and nutritional supplements and other
products that are ingested by consumers or applied to their
bodies, we have been and are currently subjected to various
product liability claims. The effects of these claims to date
have not been material to us, and the reasonably possible range
of exposure on currently existing claims is not material to us.
We believe that we have meritorious defenses to the allegations
contained in the lawsuits. We currently maintain product
liability insurance with an annual deductible of
$10 million.
Certain of our subsidiaries have been subject to tax audits by
governmental authorities in their respective countries. In
certain of these tax audits, governmental authorities are
proposing that significant amounts of additional taxes and
related interest and penalties are due. We and our tax advisors
believe that there are substantial defenses to their allegations
that additional taxes are owed, and we are vigorously contesting
the additional proposed taxes and related charges.
These matters may take several years to resolve, and we cannot
be sure of their ultimate resolution. However, it is the opinion
of management that adverse outcomes, if any, will not likely
result in a material effect on our financial condition and
operating results. This opinion is based on our belief that any
losses we suffer would not be material and that we have
meritorious defenses. Although we have reserved an amount that
we believe represents the likely outcome of the resolution of
these disputes, if we are incorrect in our assessment, we may
have to record additional expenses.
Critical
Accounting Policies
Our Consolidated Financial Statements are prepared in conformity
with U.S. GAAP, which require us to make estimates and
assumptions that affect the reported amounts of assets and
liabilities and disclosures of contingent
30
assets and liabilities at the date of the financial statements
and the reported amounts of revenue and expenses during the
year. Actual results could differ from those estimates. We
consider the following policies to be most critical in
understanding the judgments that are involved in preparing the
financial statements and the uncertainties that could impact our
operating results, financial condition and cash flows.
We are a network marketing company that sells a wide range of
weight management products, nutritional supplements, energy,
sports & fitness products and personal care products
within one industry segment as defined under Statement of
Financial Accounting Standards, or SFAS, No. 131,
Disclosures about Segments of an Enterprise and Related
Information. Our products are manufactured by third party
providers and then sold to independent distributors who sell
Herbalife products to retail consumers or other distributors. We
sell products in 70 countries throughout the world and we
are organized and managed by geographic region. We have elected
to aggregate our operating segments into one reporting segment,
except China, as management believes that our operating segments
have similar operating characteristics and similar long term
operating performance. In making this determination, management
believes that the operating segments are similar in the nature
of the products sold, the product acquisition process, the types
of customers to whom products are sold, the methods used to
distribute the products, and the nature of the regulatory
environment.
Revenue is recognized when products are shipped and title passes
to the independent distributor or importer or as products are
sold in our retail stores in China. Amounts billed for freight
and handling costs are included in net sales. We generally
receive the net sales price in cash or through credit card
payments at the point of sale. Related royalty overrides and
allowances for product returns are recorded when the merchandise
is shipped.
Allowances for product returns, primarily in connection with our
buyback program, are provided at the time the product is
shipped. This accrual is based upon historic return rates for
each country and the relevant return pattern, which reflects
anticipated returns to be received over a period of up to
12 months following the original sale. Historically,
product returns and buybacks have not been significant. Product
returns and buybacks were approximately 0.6% and 0.8% of retail
sales for the three months ended March 31, 2009 and 2008,
respectively.
We record reserves against our inventory to provide for
estimated obsolete or unsalable inventory based on assumptions
about future demand for our products and market conditions. If
future demand and market conditions are less favorable than
managements assumptions, additional reserves could be
required. Likewise, favorable future demand and market
conditions could positively impact future operating results if
previously reserved for inventory is sold. We reserved for
obsolete and slow moving inventory totaling $11.9 million
and $11.6 million as of March 31, 2009 and
December 31, 2008, respectively.
In accordance with SFAS No. 144, Accounting for the
Impairment or Disposal of Long-Lived Assets, such as
property, plant, and equipment, and purchased intangibles
subject to amortization, are reviewed for impairment whenever
events or changes in circumstances indicate that the carrying
amount of an asset may not be recoverable. Recoverability of
assets to be held and used is measured by a comparison of the
carrying amount of an asset to estimated undiscounted future
cash flows expected to be generated by the asset. If the
carrying amount of an asset exceeds its estimated future cash
flows, an impairment charge is recognized by the amount by which
the carrying amount of the asset exceeds the fair value of the
asset. Assets to be disposed of would be separately presented in
the balance sheet and reported at the lower of the carrying
amount or fair value less costs to sell, and are no longer
depreciated. The assets and liabilities of a disposed group
classified as held for sale would be presented separately in the
appropriate asset and liability sections of the balance sheet.
Goodwill and other intangibles not subject to amortization are
tested annually for impairment, and are tested for impairment
more frequently if events and circumstances indicate that the
asset might be impaired. An impairment loss is recognized to the
extent that the carrying amount exceeds the assets fair
value. This determination is made at the reporting unit level
and consists of two steps. First, we determine the fair value of
a reporting unit and compare it to its carrying amount. Second,
if the carrying amount of a reporting unit exceeds its fair
value, an impairment loss is recognized for any excess of the
carrying amount of the reporting units goodwill and other
intangibles over the implied fair value. The implied fair value
is determined by allocating the fair value of the reporting unit
in a manner similar to a purchase price allocation, in
accordance with SFAS No. 141R, Business
Combinations. The residual fair value after this allocation
is the implied fair value of the reporting units goodwill
and other intangibles. As of March 31, 2009 and
December 31, 2008, we had goodwill of approximately
31
$110.7 million and marketing franchise of
$310.0 million. No marketing related intangibles or
goodwill impairment was recorded during the three months ended
March 31, 2009 and 2008.
Contingencies are accounted for in accordance with
SFAS No. 5, Accounting for Contingencies, or
SFAS 5. SFAS 5 requires that we record an estimated
loss from a loss contingency when information available prior to
issuance of our financial statements indicates that it is
probable that an asset has been impaired or a liability has been
incurred at the date of the financial statements and the amount
of the loss can be reasonably estimated. Accounting for
contingencies such as legal and income tax matters requires us
to use judgment. Many of these legal and tax contingencies can
take years to be resolved. Generally, as the time period
increases over which the uncertainties are resolved, the
likelihood of changes to the estimate of the ultimate outcome
increases.
Deferred income tax assets have been established for net
operating loss carryforwards of certain foreign subsidiaries and
have been reduced by a valuation allowance to reflect them at
amounts estimated to be ultimately realized. The net operating
loss carryforwards expire in varying amounts over a future
period of time. Realization of the income tax carryforwards is
dependent on generating sufficient taxable income prior to
expiration of the carryforwards. Although realization is not
assured, we believe it is more likely than not that the net
carrying value of the income tax carryforwards will be realized.
The amount of the income tax carryforwards that is considered
realizable, however, could change if estimates of future taxable
income during the carryforward period are adjusted.
We account for stock-based compensation in accordance with
SFAS No. 123R, Share-Based Payment, or
SFAS 123R. Under the fair value recognition provisions of
this statement, share-based compensation cost is measured at the
grant date based on the value of the award and is recognized as
an expense over the vesting period. Determining the fair value
of share-based awards at the grant date requires judgment,
including estimating our stock price volatility and employee
stock award exercise behaviors. Our expected volatility is
primarily based upon the historical volatility of our common
shares and, due to the limited period of public trading data for
our common shares, it is also validated against the volatility
of a company peer group. The expected life of awards is based on
the simple average of the average vesting period and the life of
the award. As stock-based compensation expense recognized in the
Statements of Income is based on awards ultimately expected to
vest, the amount of expense has been reduced for estimated
forfeitures. SFAS 123R requires forfeitures to be estimated
at the time of grant and revised, if necessary, in subsequent
periods if actual forfeitures differ from those estimates.
Forfeitures were estimated based on historical experience.
We account for uncertain tax positions in accordance with
Financial Accounting Standards Board, or FASB, Interpretation
Number 48, Income Taxes, or FIN 48. FIN 48
addressed the determination of how tax benefits claimed or
expected to be claimed on a tax return should be recorded in the
financial statements. Under FIN 48, we must recognize the
tax benefit from an uncertain tax position only if it is more
likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical
merits of the position. The tax benefits recognized in the
financial statements from such a position are measured based on
the largest benefit that has a greater than fifty percent
likelihood of being realized upon ultimate resolution.
We account for and disclose fair value measurements in
accordance with SFAS No. 157, Fair Value
Measurements, or SFAS 157. SFAS 157 clarifies the
definition of fair value, prescribes methods for measuring fair
value, establishes a fair value hierarchy based on the inputs
used to measure fair value, and expands disclosures about fair
value measurements. As discussed in Note 13, Fair Value
Measurements, to the notes to our consolidated financial
statements, we properly measure and disclose our assets and
liabilities in accordance with SFAS 157.
New
Accounting Pronouncements
In April 2009, the FASB issued FASB Staff Position
No. FAS 107-1
and Accounting Principles Board Opinion
No. 28-1,
Interim Disclosures about Fair Value of Financial
Instruments, or FSP
FAS 107-1.
FSP
FAS 107-1
amends FASB Statement No. 107, Disclosures about Fair
Value of Financial Instruments, to require disclosures about
fair value of financial instruments for interim reporting
periods of publicly traded companies as well as in annual
financial statements. FSP
FAS 107-1
also amends Accounting Principles Board Opinion No. 28,
Interim Financial Reporting, to require those disclosures
in summarized financial information at interim reporting
periods. FSP
FAS 107-1
shall be effective for interim reporting periods ending after
June 15, 2009, with early adoption permitted for periods
ending after March 15, 2009. We have elected to adopt FSP
FAS 107-1
for our interim period
32
ending June 30, 2009, and believe the adoption of FSP
FAS 107-1
will not have a material impact to our consolidated financial
statements.
|
|
Item 3.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
We are exposed to market risks, which arise during the normal
course of business from changes in interest rates and foreign
currency exchange rates. On a selected basis, we use derivative
financial instruments to manage or hedge these risks. All
hedging transactions are authorized and executed pursuant to
written guidelines and procedures.
We have adopted SFAS No. 133, Accounting for
Derivative Instruments and Hedging Activities, or
SFAS 133. SFAS 133, as amended and interpreted,
established accounting and reporting standards for derivative
instruments, including certain derivative instruments embedded
in other contracts, and for hedging activities. All derivatives,
whether designated in hedging relationships or not, are required
to be recorded on the balance sheet at fair value. If the
derivative is designated as a fair-value hedge, the changes in
the fair value of the derivative and the underlying hedged item
are recognized concurrently in earnings. If the derivative is
designated as a cash-flow hedge, changes in the fair value of
the derivative are recorded in other comprehensive income (loss)
and are recognized in the statement of operations when the
hedged item affects earnings. SFAS 133 defines the
requirements for designation and documentation of hedging
relationships as well as ongoing effectiveness assessments in
order to use hedge accounting. For a derivative that does not
qualify as a hedge, changes in fair value are recognized
concurrently in earnings.
A discussion of our primary market risk exposures and
derivatives is presented below.
Foreign
Exchange Risk
We enter into foreign exchange derivatives in the ordinary
course of business primarily to reduce exposure to currency
fluctuations attributable to intercompany transactions,
translation of local currency revenue, inventory purchases
subject to foreign currency exposure, and to partially mitigate
the impact of foreign currency rate fluctuations. With the
exception of our foreign exchange forward contracts relating to
forecasted inventory purchases, all of our foreign exchange
contracts are designated as free standing derivatives for which
hedge accounting does not apply. The changes in the fair market
value of the derivatives not qualifying as cash flow hedges are
included in selling, general and administrative expenses in our
consolidated statements of income.
The foreign exchange forward contracts are used to hedge
advances between subsidiaries and to partially mitigate the
impact of foreign currency fluctuations. Foreign exchange
average rate option contracts are also used to mitigate the
impact of foreign currency rate fluctuations. The objective of
these contracts is to neutralize the impact of foreign currency
movements on the operating results of our subsidiaries. The fair
value of forward and option contracts is based on third-party
bank quotes.
We also purchase forward contracts in order to hedge forecasted
inventory purchases that are designated as cash-flow hedges and
are subject to foreign currency exposures. We have elected to
apply the hedge accounting rules as required by SFAS 133,
for these hedges. These contracts allow us to sell Euros in
exchange for U.S. dollars at specified contract rates. As
of March 31, 2009, approximately $36 million of these
contracts were outstanding and are expected to mature over the
next nine months. Our derivative financial instruments are
recorded on the consolidated balance sheet at fair value based
on quoted market rates. These forward contracts are used to
hedge forecasted inventory purchases over specific months.
Changes in the fair value of forward contracts, excluding
forward points, designated as cash-flow hedges are recorded in
other comprehensive income (loss), and are recognized in cost of
sales in the period which approximates the time the hedged
inventory is sold. As of March 31, 2009 we recorded an
asset at fair value of $1.5 million.
As of March 31, 2009, all of our foreign exchange forward
contracts had a maturity of less than one year, with the
majority expiring within 90 days. As of March 31,
2009, there were no outstanding foreign exchange option
contracts.
33
The following table provides information about the details of
our foreign exchange forward contracts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
Fair
|
|
|
|
Contract
|
|
|
Notional
|
|
|
Value
|
|
Foreign Currency
|
|
Rate
|
|
|
Amount
|
|
|
Gain (Loss)
|
|
|
|
|
|
|
(In millions)
|
|
|
(In millions)
|
|
|
At March 31, 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
Buy EUR sell MXN
|
|
|
19.03
|
|
|
$
|
42.3
|
|
|
$
|
(0.3
|
)
|
Buy EUR sell HKD
|
|
|
10.20
|
|
|
$
|
1.5
|
|
|
$
|
|
|
Buy SEK sell EUR
|
|
|
10.95
|
|
|
$
|
1.9
|
|
|
$
|
|
|
Buy MYR sell EUR
|
|
|
4.84
|
|
|
$
|
0.7
|
|
|
$
|
|
|
Buy DKK sell EUR
|
|
|
7.45
|
|
|
$
|
1.4
|
|
|
$
|
|
|
Buy EUR sell CLP
|
|
|
775.75
|
|
|
$
|
0.8
|
|
|
$
|
|
|
Buy EUR sell ARG
|
|
|
5.08
|
|
|
$
|
9.1
|
|
|
$
|
(0.2
|
)
|
Buy ARG sell EUR
|
|
|
5.02
|
|
|
$
|
1.0
|
|
|
$
|
|
|
Buy TWD sell EUR
|
|
|
45.11
|
|
|
$
|
4.7
|
|
|
$
|
|
|
Buy GBP sell EUR
|
|
|
0.93
|
|
|
$
|
6.1
|
|
|
$
|
|
|
Buy USD sell EUR
|
|
|
1.34
|
|
|
$
|
88.6
|
|
|
$
|
1.0
|
|
Buy JPN sell USD
|
|
|
97.45
|
|
|
$
|
7.2
|
|
|
$
|
(0.1
|
)
|
Buy USD sell CAD
|
|
|
1.26
|
|
|
$
|
1.6
|
|
|
$
|
|
|
Buy GBP sell USD
|
|
|
1.42
|
|
|
$
|
1.0
|
|
|
$
|
|
|
Buy USD sell BRL
|
|
|
2.36
|
|
|
$
|
5.7
|
|
|
$
|
(0.1
|
)
|
Buy CLP sell USD
|
|
|
580.00
|
|
|
$
|
2.8
|
|
|
$
|
|
|
Buy USD sell INR
|
|
|
51.77
|
|
|
$
|
3.7
|
|
|
$
|
(0.1
|
)
|
Buy JPN sell USD
|
|
|
97.45
|
|
|
$
|
1.0
|
|
|
$
|
|
|
Buy MXN sell USD
|
|
|
14.45
|
|
|
$
|
2.0
|
|
|
$
|
|
|
Buy USD sell RUB
|
|
|
34.41
|
|
|
$
|
1.1
|
|
|
$
|
|
|
Buy HKD sell USD
|
|
|
7.75
|
|
|
$
|
2.9
|
|
|
$
|
|
|
Buy USD sell PHP
|
|
|
48.59
|
|
|
$
|
2.3
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total forward contracts
|
|
|
|
|
|
$
|
189.4
|
|
|
$
|
0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Most of our foreign subsidiaries designate their local
currencies as their functional currencies. At March 31,
2009 and December 31, 2008, the total amount of our foreign
subsidiary cash was $183.4 million and $142.0 million,
respectively, of which $8.7 million and $9.7 million,
respectively, was invested in U.S. dollars.
Interest
Rate Risk
As of March 31, 2009, the aggregate annual maturities of
our senior secured credit facility entered into on
July 2006, as amended, were: 2009-$1.1 million;
2010-$1.5 million; 2011-$1.5 million;
2012-$183.5 million and $140.9 million in 2013. The
fair value of our senior secured credit facility approximates
its carrying value of $328.5 million as of March 31,
2009 and $324.5 million as of December 31, 2008. Our
senior secured credit facility bears a variable interest rate,
and on March 31, 2009 and December 31, 2008, the
weighted average interest rate was 2.20% and 3.04%, respectively.
Under our senior secured credit facility, we are obligated to
enter into an interest rate hedge for up to 25% of the aggregate
principal amount of the term loan for a minimum of three years.
On August 23, 2006, we entered into a new interest rate
swap agreement. This agreement provides for us to pay interest
for a three-year period at a fixed rate of 5.26% on the initial
notional principal amount of $180.0 million while receiving
interest for the same period at the LIBOR rate on the same
notional principal amount. The notional amount is scheduled to
be reduced by $20.0 million in the second, third and fourth
quarters of each year commencing January 1, 2007,
throughout the term of the swap. The swap has been designated as
a cash flow hedge against the variability in LIBOR interest rate
34
on the new term loan at LIBOR plus 1.50%, thereby fixing our
effective rate on the notional amounts at 6.76%. As of
December 31, 2008, the swap notional amount was
$40.0 million. As of March 31, 2009, the swap notional
amount was $40.0 million. As of March 31, 2009 and
December 31, 2008, we recorded the interest rate swap as a
liability at fair value of $0.6 million and
$1.0 million, respectively, with the offsetting amounts
recorded in other comprehensive income.
|
|
Item 4.
|
Controls
And Procedures
|
Evaluation of Disclosure Controls and
Procedures. Our management, including our Chief
Executive Officer and Chief Financial Officer, has evaluated the
effectiveness of our disclosure controls and procedures (as such
term is defined in
Rules 13a-15(e)
and
15d-15(e)
under the Securities Exchange Act of 1934, as amended, or the
Exchange Act) as of the end of the period covered by this
Quarterly Report on
Form 10-Q.
Based on such evaluation, our Chief Executive Officer and our
Chief Financial Officer have concluded that our disclosure
controls and procedures were effective as of March 31, 2009.
Changes in Internal Control over Financial
Reporting. There were no changes in our internal
control over financial reporting (as defined in
Rules 13a-15(f)
and 15d-(f)
under the Exchange Act) that occurred during the fiscal quarter
ended March 31, 2009 that have materially affected, or are
reasonably likely to materially affect, our internal control
over financial reporting.
FORWARD
LOOKING STATEMENTS
This document contains forward-looking statements
within the meaning of Section 27A of the Securities Act of
1933, as amended and Section 21E of the Securities Exchange
Act of 1934, as amended. All statements other than statements of
historical fact are forward-looking statements for
purposes of federal and state securities laws, including any
projections of earnings, revenue or other financial items; any
statements of the plans, strategies and objectives of management
for future operations; any statements concerning proposed new
services or developments; any statements regarding future
economic conditions or performance; any statements of belief;
and any statements of assumptions underlying any of the
foregoing. Forward-looking statements may include the words
may, will, estimate,
intend, continue, believe,
expect or anticipate and any other
similar words.
Although we believe that the expectations reflected in any of
our forward-looking statements are reasonable, actual results
could differ materially from those projected or assumed in any
of our forward-looking statements. Our future financial
condition and results of operations, as well as any
forward-looking statements, are subject to change and to
inherent risks and uncertainties, such as those disclosed or
incorporated by reference in our filings with the Securities and
Exchange Commission. Important factors that could cause our
actual results, performance and achievements, or industry
results to differ materially from estimates or projections
contained in our forward-looking statements include, among
others, the following:
|
|
|
|
|
our relationship with, and our ability to influence the actions
of, our distributors;
|
|
|
|
adverse publicity associated with our products or network
marketing organization;
|
|
|
|
uncertainties relating to interpretation and enforcement of
recently enacted legislation in China governing direct selling;
|
|
|
|
our inability to obtain the necessary licenses to expand our
direct selling business in China;
|
|
|
|
adverse changes in the Chinese economy, Chinese legal system or
Chinese governmental policies;
|
|
|
|
improper action by our employees or international distributors
in violation of applicable law;
|
|
|
|
changing consumer preferences and demands;
|
|
|
|
loss or departure of any member of our senior management team
which could negatively impact our distributor relations and
operating results;
|
|
|
|
the competitive nature of our business;
|
35
|
|
|
|
|
regulatory matters governing our products, including potential
governmental or regulatory actions concerning the safety or
efficacy of our products, and network marketing program
including the direct selling market in which we operate;
|
|
|
|
risks associated with operating internationally, including
foreign exchange and devaluation risks;
|
|
|
|
our dependence on increased penetration of existing markets;
|
|
|
|
contractual limitations on our ability to expand our business;
|
|
|
|
our reliance on our information technology infrastructure and
outside manufacturers;
|
|
|
|
the sufficiency of trademarks and other intellectual property
rights;
|
|
|
|
product concentration;
|
|
|
|
our reliance on our management team;
|
|
|
|
uncertainties relating to the application of transfer pricing,
duties, value added taxes, and other tax regulations, and
changes thereto;
|
|
|
|
taxation relating to our distributors;
|
|
|
|
product liability claims;
|
|
|
|
any collateral impact resulting from the ongoing worldwide
financial crisis, including the availability of
liquidity to us, our customers and our suppliers or the
willingness of our customers to purchase products in a
recessionary economic environment; and
|
|
|
|
whether we will purchase any of our shares in the open markets
or otherwise.
|
Additional factors that could cause actual results to differ
materially from our forward-looking statements are set forth in
this Quarterly Report on
Form 10-Q,
including under the heading Risk Factors,
Managements Discussion and Analysis of Financial
Condition and Results of Operations and in our
Consolidated Financial Statements and the related Notes.
Forward-looking statements in this Quarterly Report on
Form 10-Q
speak only as of the date hereof, and forward-looking statements
in documents attached that are incorporated by reference speak
only as of the date of those documents. We do not undertake any
obligation to update or release any revisions to any
forward-looking statement or to report any events or
circumstances after the date hereof or to reflect the occurrence
of unanticipated events, except as required by law.
PART II.
OTHER INFORMATION
|
|
Item 1.
|
Legal
Proceedings
|
See discussion under Note 4, Contingencies, to the
Notes to the Consolidated Financial Statements included in
Item 1 of Part I of this Quarterly Report on
Form 10-Q,
which is incorporated herein by reference.
The
worldwide financial and economic crisis could
negatively impact our access to credit and the sales of our
products and could harm our financial condition and operating
results.
We are closely monitoring various aspects of the current
worldwide financial and economic crisis and its
potential impact on us, our liquidity, our access to capital,
our operations and our overall financial condition. While we
have historically met our funding needs utilizing cash flow from
operating activities and while we believe we will have
sufficient resources to meet current debt service obligations in
a timely manner, no assurances can be given that the current
overall downturn in the world economy will not significantly
adversely impact us and our business operations. We note
economic and financial markets are fluid and we cannot ensure
that there will not be in the near future a material adverse
deterioration in our sales or liquidity.
36
Our
failure to establish and maintain distributor relationships for
any reason could negatively impact sales of our products and
harm our financial condition and operating
results.
We distribute our products exclusively through over
1.9 million independent distributors, and we depend upon
them directly for substantially all of our sales. To increase
our revenue, we must increase the number of, or the productivity
of, our distributors. Accordingly, our success depends in
significant part upon our ability to recruit, retain and
motivate a large base of distributors. There is a high rate of
turnover among our distributors, which is a characteristic of
the network marketing business. The loss of a significant number
of distributors for any reason could negatively impact sales of
our products and could impair our ability to attract new
distributors. In our efforts to attract and retain distributors,
we compete with other network marketing organizations, including
those in the weight management, dietary and nutritional
supplement and personal care and cosmetic product industries.
Our operating results could be harmed if our existing and new
business opportunities and products do not generate sufficient
interest to retain existing distributors and attract new
distributors.
Our distributor organization has a high turnover rate, which is
a common characteristic found in the direct selling industry. In
light of this fact, we have our supervisors re-qualify annually
in order to maintain a more accurate count of their numbers. For
the latest twelve month re-qualification period ending January
2009, 40.3% of our supervisors re-qualified. Distributors who
purchase our product for personal consumption or for short-term
income goals may stay with us for several months to one year.
Supervisors who have committed time and effort to build a sales
organization will generally stay for longer periods.
Distributors have highly variable levels of training, skills and
capabilities. The turnover rate of our distributors, and our
operating results, can be adversely impacted if we, and our
senior distributor leadership, do not provide the necessary
mentoring, training and business support tools for new
distributors to become successful sales people in a short period
of time.
We estimate that, of our over 1.9 million independent
distributors, we had approximately 341,000 sales leaders as of
March 31, 2009. These sales leaders, together with their
downline sales organizations, account for substantially all of
our revenues. Our distributors, including our sales leaders, may
voluntarily terminate their distributor agreements with us at
any time. The loss of a group of leading sales leaders, together
with their downline sales organizations, or the loss of a
significant number of distributors for any reason, could
negatively impact sales of our products, impair our ability to
attract new distributors and harm our financial condition and
operating results.
Since
we cannot exert the same level of influence or control over our
independent distributors as we could were they our own
employees, our distributors could fail to comply with our
distributor policies and procedures, which could result in
claims against us that could harm our financial condition and
operating results.
Excluding our China sales employees, our distributors are
independent contractors and, accordingly, we are not in a
position to directly provide the same direction, motivation and
oversight as we would if distributors were our own employees. As
a result, there can be no assurance that our distributors will
participate in our marketing strategies or plans, accept our
introduction of new products, or comply with our distributor
policies and procedures.
Extensive federal, state and local laws regulate our business,
products and network marketing program. Because we have expanded
into foreign countries, our policies and procedures for our
independent distributors differ due to the different legal
requirements of each country in which we do business. While we
have implemented distributor policies and procedures designed to
govern distributor conduct and to protect the goodwill
associated with Herbalife trademarks and tradenames, it can be
difficult to enforce these policies and procedures because of
the large number of distributors and their independent status.
Violations by our independent distributors of applicable law or
of our policies and procedures in dealing with customers could
reflect negatively on our products and operations and harm our
business reputation. In addition, it is possible that a court
could hold us civilly or criminally accountable based on
vicarious liability because of the actions of our independent
distributors.
37
Adverse
publicity associated with our products, ingredients or network
marketing program, or those of similar companies, could harm our
financial condition and operating results.
The size of our distribution force and the results of our
operations may be significantly affected by the publics
perception of the Company and similar companies. This perception
is dependent upon opinions concerning:
|
|
|
|
|
the safety and quality of our products and ingredients;
|
|
|
|
the safety and quality of similar products and ingredients
distributed by other companies;
|
|
|
|
our distributors;
|
|
|
|
our network marketing program; and
|
|
|
|
the direct selling business generally.
|
Adverse publicity concerning any actual or purported failure of
our Company or our independent distributors to comply with
applicable laws and regulations regarding product claims and
advertising, good manufacturing practices, the regulation of our
network marketing program, the licensing of our products for
sale in our target markets or other aspects of our business,
whether or not resulting in enforcement actions or the
imposition of penalties, could have an adverse effect on the
goodwill of our Company and could negatively affect our ability
to attract, motivate and retain distributors, which would
negatively impact our ability to generate revenue. We cannot
ensure that all distributors will comply with applicable legal
requirements relating to the advertising, labeling, licensing or
distribution of our products.
In addition, our distributors and consumers
perception of the safety and quality of our products and
ingredients as well as similar products and ingredients
distributed by other companies can be significantly influenced
by media attention, publicized scientific research or findings,
widespread product liability claims and other publicity
concerning our products or ingredients or similar products and
ingredients distributed by other companies. For example, in May
2008 public allegations were made that certain of our products
contain excessive amounts of lead thereby triggering disclosure
and labeling requirements under California Proposition 65. While
we have confidence in our products because they fall within the
FDA suggested guidelines for the amount of lead that consumers
can safely ingest and do not believe they trigger disclosure or
labeling requirements under California Proposition 65, negative
publicity such as this can disrupt our business. Adverse
publicity, whether or not accurate or resulting from
consumers use or misuse of our products, that associates
consumption of our products or ingredients or any similar
products or ingredients with illness or other adverse effects,
questions the benefits of our or similar products or claims that
any such products are ineffective, inappropriately labeled or
have inaccurate instructions as to their use, could lead to
lawsuits or other legal challenges and could negatively impact
our reputation, the market demand for our products, or our
general business.
From time to time we receive inquiries from government agencies
and third parties requesting information concerning our
products. We fully cooperate with these inquiries including,
when requested, by the submission of detailed technical dossiers
addressing product composition, manufacturing, process control,
quality assurance, and contaminant testing. We understand that
such materials are undergoing review by regulators in certain
markets. In the course of one such inquiry the Spanish Ministry
of Health elected to issue a press release, or a communicado, to
inform the public of their on-going inquiry and dialogue with
our Company. Upon completion of its review of Herbalife products
distributed in Spain, the Spanish Ministry of Health withdrew
its communicado. We are confident in the safety of our products
when used as directed. However, there can be no assurance that
regulators in these or other markets will not take actions that
might delay or prevent the introduction of new products, or
require the reformulation or the temporary or permanent
withdrawal of certain of our existing products from their
markets.
Adverse publicity relating to us, our products or our
operations, including our network marketing program or the
attractiveness or viability of the financial opportunities
provided thereby, has had, and could again have, a negative
effect on our ability to attract, motivate and retain
distributors. In the mid-1980s, our products and marketing
program became the subject of regulatory scrutiny in the United
States, resulting in large part from claims and representations
made about our products by our independent distributors,
including impermissible therapeutic claims. The resulting
adverse publicity caused a rapid, substantial loss of
distributors in the United
38
States and a corresponding reduction in sales beginning in 1985.
We expect that negative publicity will, from time to time,
continue to negatively impact our business in particular markets.
Our
failure to appropriately respond to changing consumer
preferences and demand for new products or product enhancements
could significantly harm our distributor and customer
relationships and product sales and harm our financial condition
and operating results.
Our business is subject to changing consumer trends and
preferences, especially with respect to weight management
products. Our continued success depends in part on our ability
to anticipate and respond to these changes, and we may not
respond in a timely or commercially appropriate manner to such
changes. Furthermore, the nutritional supplement industry is
characterized by rapid and frequent changes in demand for
products and new product introductions and enhancements. Our
failure to accurately predict these trends could negatively
impact consumer opinion of our products, which in turn could
harm our customer and distributor relationships and cause the
loss of sales. The success of our new product offerings and
enhancements depends upon a number of factors, including our
ability to:
|
|
|
|
|
accurately anticipate customer needs;
|
|
|
|
innovate and develop new products or product enhancements that
meet these needs;
|
|
|
|
successfully commercialize new products or product enhancements
in a timely manner;
|
|
|
|
price our products competitively;
|
|
|
|
manufacture and deliver our products in sufficient volumes and
in a timely manner; and
|
|
|
|
differentiate our product offerings from those of our
competitors.
|
If we do not introduce new products or make enhancements to meet
the changing needs of our customers in a timely manner, some of
our products could be rendered obsolete, which could negatively
impact our revenues, financial condition and operating results.
Due to
the high level of competition in our industry, we might fail to
retain our customers and distributors, which would harm our
financial condition and operating results.
The business of marketing weight management and nutrition
products is highly competitive and sensitive to the introduction
of new products or weight management plans, including various
prescription drugs, which may rapidly capture a significant
share of the market. These market segments include numerous
manufacturers, distributors, marketers, retailers and physicians
that actively compete for the business of consumers both in the
United States and abroad. In addition, we anticipate that we
will be subject to increasing competition in the future from
sellers that utilize electronic commerce. Some of these
competitors have longer operating histories, significantly
greater financial, technical, product development, marketing and
sales resources, greater name recognition, larger established
customer bases and better-developed distribution channels than
we do. Our present or future competitors may be able to develop
products that are comparable or superior to those we offer,
adapt more quickly than we do to new technologies, evolving
industry trends and standards or customer requirements, or
devote greater resources to the development, promotion and sale
of their products than we do. For example, if our competitors
develop other diet or weight loss treatments that prove to be
more effective than our products, demand for our products could
be reduced. Accordingly, we may not be able to compete
effectively in our markets and competition may intensify.
We are also subject to significant competition for the
recruitment of distributors from other network marketing
organizations, including those that market weight management
products, dietary and nutritional supplements and personal care
products as well as other types of products. We compete for
global customers and distributors with regard to weight
management, nutritional supplement and personal care products.
Our competitors include both direct selling companies such as
NuSkin Enterprises, Natures Sunshine, Alticor/Amway,
Melaleuca, Avon Products, Oriflame and Mary Kay, as well as
retail establishments such as Weight Watchers, Jenny Craig,
General Nutrition Centers, Wal-Mart and retail pharmacies.
39
In addition, because the industry in which we operate is not
particularly capital intensive or otherwise subject to high
barriers to entry, it is relatively easy for new competitors to
emerge who will compete with us for our distributors and
customers. In addition, the fact that our distributors may
easily enter and exit our network marketing program contributes
to the level of competition that we face. For example, a
distributor can enter or exit our network marketing system with
relative ease at any time without facing a significant
investment or loss of capital because (1) we have a low
upfront financial cost to become a Herbalife distributor,
(2) we do not require any specific amount of time to work
as a distributor, (3) we do not insist on any special
training to be a distributor and (4) we do not prohibit a
new distributor from working with another company. Our ability
to remain competitive therefore depends, in significant part, on
our success in recruiting and retaining distributors through an
attractive compensation plan, the maintenance of an attractive
product portfolio and other incentives. We cannot ensure that
our programs for recruitment and retention of distributors will
be successful and if they are not, our financial condition and
operating results would be harmed.
We are
affected by extensive laws, governmental regulations,
administrative determinations, court decisions and similar
constraints both domestically and abroad, and our failure or our
distributors failure to comply with these restraints could
lead to the imposition of significant penalties or claims, which
could harm our financial condition and operating
results.
In both domestic and foreign markets, the formulation,
manufacturing, packaging, labeling, distribution, importation,
exportation, licensing, sale and storage of our products are
affected by extensive laws, governmental regulations,
administrative determinations, court decisions and similar
constraints. Such laws, regulations and other constraints may
exist at the federal, state or local levels in the United States
and at all levels of government in foreign jurisdictions. There
can be no assurance that we or our distributors are in
compliance with all of these regulations. Our failure or our
distributors failure to comply with these regulations or
new regulations could lead to the imposition of significant
penalties or claims and could negatively impact our business. In
addition, the adoption of new regulations or changes in the
interpretations of existing regulations may result in
significant compliance costs or discontinuation of product sales
and may negatively impact the marketing of our products,
resulting in significant loss of sales revenues.
In April 2006, the FTC issued a notice of proposed rulemaking
which, if implemented in its originally proposed form, would
have regulated all sellers of business opportunities
in the United States. As originally proposed this rule would
have applied to us and, if adopted in its proposed form, could
have adversely impacted our U.S. business. On
March 18, 2008, the FTC issued a revised proposed rule and,
as indicated in the announcement accompanying the proposed rule,
the revised proposal does not attempt to cover multilevel
marketing companies such as Herbalife. If the revised rule were
implemented as it is now proposed, we believe that it would not
significantly impact our U.S. business. Based on
information currently available, we anticipate that the rule may
require a year or more to become final.
The FTC has requested comments on amendments to its Guides
Concerning the Use of Endorsements and Testimonials in
Advertising, or Guides. Although the Guides are not binding,
they explain how the FTC interprets Section 5 of the FTC
Acts prohibition on unfair or deceptive acts or practices.
Consequently, the FTC could bring a Section 5 enforcement
action based on practices that are inconsistent with the Guides.
Under the proposal, a statement reflecting a consumer
endorsers experience concerning a key attribute of the
product generally would not be permissible with only a
disclaimer of typicality (e.g., Results Not
Typical). Instead, if the advertiser does not have
substantiation that the endorsers experience is
representative of what other consumers will generally achieve,
the advertiser would be required to disclose clearly and
conspicuously the generally expected performance of the product
or service under the depicted circumstances and have adequate
substantiation for that representation. The FTC has requested
that comments concerning its proposed rule on product
endorsements and testimonials be submitted by interested parties
by January 30, 2009. If the Guides are amended and enforced
by the FTC as presently proposed, marketing with the use of
testimonials regarding consumer products, including but not
limited those for market weight-management products, would be
significantly impacted and might negatively effect our sales.
Governmental regulations in countries where we plan to commence
or expand operations may prevent or delay entry into those
markets. In addition, our ability to sustain satisfactory levels
of sales in our markets is dependent in
40
significant part on our ability to introduce additional products
into such markets. However, governmental regulations in our
markets, both domestic and international, can delay or prevent
the introduction, or require the reformulation or withdrawal, of
certain of our products. For example, during the third quarter
of 1995, we received inquiries from certain governmental
agencies within Germany and Portugal regarding our product,
Thermojetics®
Instant Herbal Beverage, relating to the caffeine content of
the product and the status of the product as an instant
tea, which was disfavored by regulators, versus a
beverage. Although we initially suspended the
product sale in Germany and Portugal at the request of the
regulators, we successfully reintroduced it once regulatory
issues were satisfactorily resolved. In another example, during
the second quarter of 2008 the Spanish Ministry of Health issued
a press release, or a communicado, informing the public of its
on-going inquiry into the safety of our Companys products
sold in Spain. Upon completion of its review of Herbalife
products distributed in Spain, the Spanish Ministry of Health
withdrew its communicado. Any such regulatory action, whether or
not it results in a final determination adverse to us, could
create negative publicity, with detrimental effects on the
motivation and recruitment of distributors and, consequently, on
sales.
On June 25, 2007, the FDA published its final rule for
cGMPs affecting the manufacture, packing, and holding of dietary
supplements. The final rule requires identity testing on all
incoming dietary ingredients, but permits the use of
certificates of analysis or other documentation to verify the
reliability of the ingredient suppliers. On the same date the
FDA also published an interim final rule that outlined a
petition process for manufacturers to request an exemption to
the cGMP requirement for 100 percent identity testing of
specific dietary ingredients used in the processing of dietary
supplements. Under the interim final rule the manufacturer may
be exempted from the dietary ingredient testing requirement if
it can provide sufficient documentation that the reduced
frequency of testing requested would still ensure the identity
of the dietary ingredient. The final rule includes a phased-in
effective date based on the size of the manufacturer. The final
rule and the interim final rule became effective August 24,
2007. To limit any disruption for dietary supplements produced
by small businesses the final rule has a three year phase in for
small businesses. Firms that directly employ more than
500 full-time equivalent employees must have achieved
compliance with the new cGMPs by June 25, 2008, while firms
having between
20-500 full-time
equivalent employees must be compliant by 2009 and firms having
under 20 full-time equivalent employees must be compliant
by 2010. Herbalife initiated enhancements, modifications and
improvements to its manufacturing and corporate quality
processes and believes we are compliant with the FDAs cGMP
final rule with respect to dietary supplements sold by Herbalife
in the United States that the Company produces at its Suzhou,
China facility and that are produced by contract manufacturer
NBTY. These rules apply only to manufacturers and holders of
finished products and not to ingredient suppliers unless the
ingredient supplier is manufacturing a final dietary supplement.
The final rule differs from the FDAs 2003 proposed rule as
it does not contain language regarding the regulatory status of
excipients and other ingredients that are not dietary
ingredients. Instead, the final rule relies on a
requirement to comply with all other relevant regulations.
Further, the final rule does not call for any specific finished
product testing program nor does it require 100% testing of all
finished products. Instead the final rule calls for a
scientifically valid system for ensuring that
finished products meet all specifications. Due to the final cGMP
rules, we have experienced increases in some product costs as a
result of the necessary increase in testing of raw ingredients
and finished products and this may cause us to seek alternate
suppliers.
Our
network marketing program could be found to be not in compliance
with current or newly adopted laws or regulations in one or more
markets, which could prevent us from conducting our business in
these markets and harm our financial condition and operating
results.
Our network marketing program is subject to a number of federal
and state regulations administered by the FTC and various state
agencies in the United States as well as regulations on direct
selling in foreign markets administered by foreign agencies. We
are subject to the risk that, in one or more markets, our
network marketing program could be found not to be in compliance
with applicable law or regulations. Regulations applicable to
network marketing organizations generally are directed at
preventing fraudulent or deceptive schemes, often referred to as
pyramid or chain sales schemes, by
ensuring that product sales ultimately are made to consumers and
that advancement within an organization is based on sales of the
organizations products rather than investments in the
organization or other non-retail sales-related criteria. The
regulatory requirements concerning network marketing programs do
not include bright line rules and are inherently
fact-based, and thus, even in jurisdictions where we believe
that our network marketing program is in full compliance with
applicable laws or regulations
41
governing network marketing systems, we are subject to the risk
that these laws or regulations or the enforcement or
interpretation of these laws and regulations by governmental
agencies or courts can change. The failure of our network
marketing program to comply with current or newly adopted
regulations could negatively impact our business in a particular
market or in general.
We are also subject to the risk of private party challenges to
the legality of our network marketing program. The multi-level
marketing programs of other companies have been successfully
challenged in the past and in a current lawsuit, allegations
have been made challenging the legality of our network marketing
program in Belgium. Test Ankoop-Test Achat, a Belgian consumer
protection organization, sued Herbalife International Belgium,
S.V., or HIB, on August 26, 2004, alleging that HIB
violated Article 84 of the Belgian Fair Trade Practices Act
by engaging in pyramid selling, i.e., establishing a
network of professional or non-professional sales people who
hope to make a profit more through the expansion of that network
than through the sale of products to end-consumers. The
plaintiff is seeking a payment of 25,000 (equal to
approximately $32,600 as of March 31, 2009) per
purported violation as well as costs of the trial. For the year
ended December 31, 2008, our net sales in Belgium were
approximately $16.7 million. Currently, the lawsuit is in
the pleading stage. The plaintiffs filed their initial brief on
September 27, 2005. We filed a reply brief on May 9,
2006 and on December 9, 2008 plaintiffs filed a responsive
brief. There is no date yet for the oral hearings. An adverse
judicial determination with respect to our network marketing
program, or in proceedings not involving us directly but which
challenge the legality of multi-level marketing systems, in
Belgium or in any other market in which we operate, could
negatively impact our business. We believe that we have
meritorious defenses to the suit.
A
substantial portion of our business is conducted in foreign
markets, exposing us to the risks of trade or foreign exchange
restrictions, increased tariffs, foreign currency fluctuations
and similar risks associated with foreign
operations.
Approximately 80% of our net sales for the year ended
December 31, 2008, were generated outside the
United States, exposing our business to risks associated
with foreign operations. For example, a foreign government may
impose trade or foreign exchange restrictions or increased
tariffs, which could negatively impact our operations. We are
also exposed to risks associated with foreign currency
fluctuations. For instance, purchases from suppliers are
generally made in U.S. dollars while sales to distributors
are generally made in local currencies. Accordingly,
strengthening of the U.S. dollar versus a foreign currency
could have a negative impact on us. Although we engage in
transactions to protect against risks associated with foreign
currency fluctuations, we cannot be certain any hedging activity
will effectively reduce our exchange rate exposure. Our
operations in some markets also may be adversely affected by
political, economic and social instability in foreign countries.
As we continue to focus on expanding our existing international
operations, these and other risks associated with international
operations may increase, which could harm our financial
condition and operating results.
Currency restrictions enacted by the Venezuelan government in
2003 have become more restrictive and have impacted the ability
of our subsidiary in Venezuela, or Herbalife Venezuela, to
obtain U.S. dollars at the official foreign exchange rate.
We continue to make appropriate applications through the
Venezuelan government and its Foreign Exchange Commission,
CADIVI, for approval to obtain U.S. dollars at the official
exchange rate to pay for imported product and to pay an annual
dividend. The approval process has been delayed in recent
periods and we have not been given any assurances as to when it
will be completed. Unless our ability to obtain
U.S. dollars at the official foreign exchange rate is made
more readily available, the results of Herbalife
Venezuelas operations will be negatively impacted as it
may need to obtain more U.S. dollars from alternative
sources where the exchange rate is weaker than the official rate.
Inflation in Venezuela has continued to increase over the past
few years and it is possible that Venezuela will be designated
as a highly inflationary economy during 2009. Gains and losses
resulting from the translation of the financial statements of
subsidiaries operating in highly inflationary economies are
recorded in earnings. If Venezuela is designated as a highly
inflationary economy and there is a devaluation of the official
rate, earnings could be negatively impacted.
42
Our
expansion in China is subject to general, as well as
industry-specific, economic, political and legal developments
and risks in China and requires that we utilize a different
business model from that which we use elsewhere in the
world.
Our expansion of operations into China is subject to risks and
uncertainties related to general economic, political and legal
developments in China, among other things. The Chinese
government exercises significant control over the Chinese
economy, including but not limited to controlling capital
investments, allocating resources, setting monetary policy,
controlling foreign exchange and monitoring foreign exchange
rates, implementing and overseeing tax regulations, providing
preferential treatment to certain industry segments or companies
and issuing necessary licenses to conduct business. Accordingly,
any adverse change in the Chinese economy, the Chinese legal
system or Chinese governmental, economic or other policies could
have a material adverse effect on our business in China and our
prospects generally.
In August 2005, China published regulations governing direct
selling (effective December 1, 2005) and prohibiting
pyramid promotional schemes (effective November 1, 2005),
and a number of administrative methods and proclamations were
issued in September 2005 and in September 2006. These
regulations require us to use a business model different from
that which we offer in other markets. To allow us to operate
under these regulations, we have created and introduced a model
specifically for China. In China, we have Company-operated
retail stores that sell through employed sales management
personnel to customers and preferred customers. We provide
training and certification procedures for sales personnel in
China. We also have non-employee sales representatives who sell
through our retail stores. Our sales representatives are also
permitted by the terms of our direct selling license to sell
away from fixed retail locations in the provinces of Jiangsu,
Guangdong, Shandong, Zhejiang (excluding Ningbo), and Guizhou.
In addition, our direct selling license for Beijing will permit
us to sell away from fixed retail locations once our Beijing
outlet is inspected and confirmed by the relevant authority.
These features are not common to the business model we employ
elsewhere in the world, and based on the direct selling licenses
we have received and the terms of those which we hope to receive
in the future to conduct a direct selling enterprise in China,
our business model in China will continue in some part to
incorporate such features. The direct selling regulations
require us to apply for various approvals to conduct a direct
selling enterprise in China. The process for obtaining the
necessary licenses to conduct a direct selling business is
protracted and cumbersome and involves multiple layers of
Chinese governmental authorities and numerous governmental
employees at each layer. While direct selling licenses are
centrally issued, such licenses are generally valid only in the
jurisdictions within which related approvals have been obtained.
Such approvals are generally awarded on local and provincial
bases, and the approval process requires involvement with
multiple ministries at each level. Our participation and conduct
during the approval process is guided not only by distinct
Chinese practices and customs, but is also subject to applicable
laws of China and the other jurisdictions in which we operate
our business, including the U.S., and our internal code of
ethics. There is always a risk that in attempting to comply with
local customs and practices in China during the application
process or otherwise, we will fail to comply with requirements
applicable to us in China itself or in other jurisdictions, and
any such failure to comply with applicable requirements could
prevent us from obtaining the direct selling licenses or related
local or provincial approvals. Furthermore, we rely on certain
key personnel in China to assist us during the approval process,
and the loss of any such key personnel could delay or hinder our
ability to obtain licenses or related approvals. For all of the
above reasons, there can be no assurance that we will obtain
additional direct-selling licenses, or obtain related approvals
to expand into any or all of the localities or provinces in
China that are important to our business. Our inability to
obtain, retain, or renew any or all of the licenses or related
approvals that are required for us to operate in China would
negatively impact our business.
Additionally, although certain regulations have been published
with respect to obtaining such approvals, operating under such
approvals and otherwise conducting business in China, other
regulations are pending, and there is uncertainty regarding the
interpretation and enforcement of Chinese regulations. The
regulatory environment in China is evolving, and officials in
the Chinese government exercise broad discretion in deciding how
to interpret and apply regulations. We cannot be certain that
our business model will continue to be deemed by national or
local Chinese regulatory authorities to be compliant with any
such regulations. In the past, the Chinese government has
rigorously monitored the direct selling market in China, and has
taken serious action against companies that the government
believed were engaging in activities they regarded to be in
violation of applicable law, including shutting down their
businesses and imposing substantial fines. As a result, there
can be no guarantee
43
that the Chinese governments current or future
interpretation and application of the existing and new
regulations will not negatively impact our business in China,
result in regulatory investigations or lead to fines or
penalties against us or our Chinese distributors.
Chinese regulations prevent persons who are not Chinese
nationals from engaging in direct selling in China. We cannot
guarantee that any of our distributors living outside of China
or any of our independent sales representatives or employed
sales management personnel in China have not engaged or will not
engage in activities that violate our policies in this market,
or that violate Chinese law or other applicable law, and
therefore result in regulatory action and adverse publicity.
China enacted a labor contract law which took effect
January 1, 2008 and on September 18, 2008 an
implementing regulation took effect. We have reviewed our
employment contracts and contractual relations with employees in
China, which include certain of our sales persons, and have made
such changes as we believed to be necessary or appropriate to
bring these contracts and contractual relations into compliance
with this new law and its implementing regulation. In addition,
we continue to monitor the situation to determine how this new
law and regulation will be implemented in practice. There is no
guarantee that the new law will not adversely impact us, force
us to change our treatment of our distributor employees, or
cause us to change our operating plan for China.
If our operations in China are successful, we may experience
rapid growth in China, and there can be no assurances that we
will be able to successfully manage rapid expansion of
manufacturing operations and a rapidly growing and dynamic sales
force. There also can be no assurances that we will not
experience difficulties in dealing with or taking employment
related actions (such as hiring, terminations and salary
administration, including social benefit payments) with respect
to our employed sales representatives, particularly given the
highly regulated nature of the employment relationship in China.
If we are unable to effectively manage such growth and expansion
of our retail stores, manufacturing operations or our employees,
our government relations may be compromised and our operations
in China may be harmed.
Our China business model, particularly with regard to sales
management responsibilities and remuneration, differs from our
traditional business model. There is a risk that such changes
and transitions may not be understood by our distributors or
employees, may be viewed negatively by our distributors or
employees, or may not be correctly utilized by our distributors
or employees. If that is the case, our business could be
negatively impacted.
If we
fail to further penetrate existing markets or successfully
expand our business into new markets, then the growth in sales
of our products, along with our operating results, could be
negatively impacted.
The success of our business is to a large extent contingent on
our ability to continue to grow by entering new markets and
further penetrating existing markets. Our ability to further
penetrate existing markets or to successfully expand our
business into additional countries in Eastern Europe, Southeast
Asia, South America or elsewhere, to the extent we believe that
we have identified attractive geographic expansion opportunities
in the future, is subject to numerous factors, many of which are
out of our control.
In addition, government regulations in both our domestic and
international markets can delay or prevent the introduction, or
require the reformulation or withdrawal, of some of our
products, which could negatively impact our business, financial
condition and results of operations. Also, our ability to
increase market penetration in certain countries may be limited
by the finite number of persons in a given country inclined to
pursue a direct selling business opportunity or consumers
willing to purchase Herbalife products. Moreover, our growth
will depend upon improved training and other activities that
enhance distributor retention in our markets. While we have
recently experienced significant growth in certain of our
markets, we cannot assure you that such growth levels will
continue in the immediate or long term future. Furthermore, our
efforts to support growth in such international markets could be
hampered to the extent that our infrastructure in such markets
is deficient when compared to our more developed markets, such
as the U.S. Therefore, we cannot assure you that our
general efforts to increase our market penetration and
distributor retention in existing markets will be successful. If
we are unable to continue to expand into new markets or further
penetrate existing markets, our operating results could suffer.
44
Our
contractual obligation to sell our products only through our
Herbalife distributor network and to refrain from changing
certain aspects of our marketing plan may limit our
growth.
We are a party to an agreement with our distributors that
provides assurances that a change in ownership will not
negatively affect certain aspects of their business. Through
this agreement, we committed to our distributors that we will
not sell Herbalife products through any distribution channel
other than our network of independent Herbalife distributors.
Thus, we are contractually prohibited from expanding our
business by selling Herbalife products through other
distribution channels that may be available to our competitors,
such as over the internet, through wholesale sales, by
establishing retail stores or through mail order systems. Since
this is an open-ended commitment, there can be no assurance that
we will be able to take advantage of innovative new distribution
channels that are developed in the future.
In addition, our agreement with our distributors provides that
we will not change certain aspects of our marketing plan without
the consent of a specified percentage of our distributors. For
example, our agreement with our distributors provides that we
may increase, but not decrease, the discount percentages
available to our distributors for the purchase of products or
the applicable royalty override percentages, including
roll-ups,
and production and other bonus percentages available to our
distributors at various qualification levels within our
distributor hierarchy. We may not modify the eligibility or
qualification criteria for these discounts, royalty overrides
and production and other bonuses unless we do so in a manner to
make eligibility
and/or
qualification easier than under the applicable criteria in
effect as of the date of the agreement. Our agreement with our
distributors further provides that we may not vary the criteria
for qualification for each distributor tier within our
distributor hierarchy, unless we do so in such a way so as to
make qualification easier.
Although we reserved the right to make these changes to our
marketing plan without the consent of our distributors in the
event that changes are required by applicable law or are
necessary in our reasonable business judgment to account for
specific local market or currency conditions to achieve a
reasonable profit on operations, there can be no assurance that
our agreement with our distributors will not restrict our
ability to adapt our marketing plan to the evolving requirements
of the markets in which we operate. As a result, our growth may
be limited.
We
depend on the integrity and reliability of our information
technology infrastructure, and any related inadequacies may
result in substantial interruptions to our
business.
Our ability to timely provide products to our distributors and
their customers, and services to our distributors, depends on
the integrity of our information technology system, which we are
in the process of upgrading, including the reliability of
software and services supplied by our vendors. We are
implementing an Oracle enterprise-wide technology solution, a
scalable and stable open architecture platform, to enhance our
and our distributors efficiency and productivity. In
addition, we are upgrading our internet-based marketing and
distributor services platform, MyHerbalife.com.
The most important aspect of our information technology
infrastructure is the system through which we record and track
distributor sales, volume points, royalty overrides, bonuses and
other incentives. We have encountered, and may encounter in the
future, errors in our software or our enterprise network, or
inadequacies in the software and services supplied by our
vendors, although to date none of these errors or inadequacies
has had a meaningful adverse impact on our business. Any such
errors or inadequacies that we may encounter in the future may
result in substantial interruptions to our services and may
damage our relationships with, or cause us to lose, our
distributors if the errors or inadequacies impair our ability to
track sales and pay royalty overrides, bonuses and other
incentives, which would harm our financial condition and
operating results. Such errors may be expensive or difficult to
correct in a timely manner, and we may have little or no control
over whether any inadequacies in software or services supplied
to us by third parties are corrected, if at all.
Since
we rely on independent third parties for the manufacture and
supply of our products, if these third parties fail to reliably
supply products to us at required levels of quality, then our
financial condition and operating results would be
harmed.
All of our products are manufactured by outside companies,
except for a small amount of products manufactured in our own
manufacturing facility in China. We cannot assure you that our
outside manufacturers
45
will continue to reliably supply products to us at the levels of
quality, or the quantities, we require, especially under the
FDAs recently adopted cGMP regulations. While we are not
presently aware of any current liquidity issues with our
suppliers, we cannot assure you that they will not experience
financial hardship as a result of the current global financial
crisis.
Our supply contracts generally have a two-year term. Except for
force majeure events such as natural disasters and other acts of
God, and non-performance by Herbalife, our manufacturers
generally cannot unilaterally terminate these contracts. These
contracts can generally be extended by us at the end of the
relevant time period and we have exercised this right in the
past. Globally we have over 40 suppliers of our products. For
our major products, we have both primary and secondary
suppliers. Our major suppliers include Natures Bounty for
protein powders, Fine Foods (Italy) for protein powders and
nutritional supplements, PharmaChem Labs for teas and
Niteworks®
and JB Labs for fiber. In the event any of our third-party
manufacturers were to become unable or unwilling to continue to
provide us with products in required volumes and at suitable
quality levels, we would be required to identify and obtain
acceptable replacement manufacturing sources. There is no
assurance that we would be able to obtain alternative
manufacturing sources on a timely basis. An extended
interruption in the supply of products would result in the loss
of sales. In addition, any actual or perceived degradation of
product quality as a result of reliance on third party
manufacturers may have an adverse effect on sales or result in
increased product returns and buybacks. Also, as we experience
ingredient and product price pressure in the areas of soy, dairy
products, plastics, and transportation reflecting global
economic trends, we believe that we have the ability to mitigate
some of these cost increases through improved optimization of
our supply chain coupled with select increases in the retail
prices of our products.
If we
fail to protect our trademarks and tradenames, then our ability
to compete could be negatively affected, which would harm our
financial condition and operating results.
The market for our products depends to a significant extent upon
the goodwill associated with our trademark and tradenames. We
own, or have licenses to use, the material trademark and trade
name rights used in connection with the packaging, marketing and
distribution of our products in the markets where those products
are sold. Therefore, trademark and trade name protection is
important to our business. Although most of our trademarks are
registered in the United States and in certain foreign countries
in which we operate, we may not be successful in asserting
trademark or trade name protection. In addition, the laws of
certain foreign countries may not protect our intellectual
property rights to the same extent as the laws of the United
States. The loss or infringement of our trademarks or tradenames
could impair the goodwill associated with our brands and harm
our reputation, which would harm our financial condition and
operating results.
Unlike in most of the other markets in which we operate, limited
protection of intellectual property is available under Chinese
law. Accordingly, we face an increased risk in China that
unauthorized parties may attempt to copy or otherwise obtain or
use our trademarks, copyrights, product formulations or other
intellectual property. Further, since Chinese commercial law is
relatively undeveloped, we may have limited legal recourse in
the event we encounter significant difficulties with
intellectual property theft or infringement. As a result, we
cannot assure you that we will be able to adequately protect our
product formulations or other intellectual property.
We permit the limited use of our trademarks by our independent
distributors to assist them in the marketing of our products. It
is possible that doing so may increase the risk of unauthorized
use or misuse of our trademarks in markets where their
registration status differs from that asserted by our
independent distributors, or they may be used in association
with claims or products in a manner not permitted under
applicable laws and regulations. Were this to occur it is
possible that this could diminish the value of these marks or
otherwise impair our further use of these marks.
If our
distributors fail to comply with labeling laws, then our
financial condition and operating results would be
harmed.
Although the physical labeling of our products is not within the
control of our independent distributors, our distributors must
nevertheless advertise our products in compliance with the
extensive regulations that exist in certain jurisdictions, such
as the United States, which considers product advertising to be
labeling for regulatory purposes.
46
Our products are sold principally as foods, dietary supplements
and cosmetics and are subject to rigorous FDA and related legal
regimens limiting the types of therapeutic claims that can be
made for our products. The treatment or cure of disease, for
example, is not a permitted claim for these products. While we
train and attempt to monitor our distributors marketing
materials, we cannot ensure that all such materials comply with
applicable regulations, including bans on therapeutic claims. If
our distributors fail to comply with these restrictions, then we
and our distributors could be subjected to claims, financial
penalties, mandatory product recalls or relabeling requirements,
which could harm our financial condition and operating results.
Although we expect that our responsibility for the actions of
our independent distributors in such an instance would be
dependent on a determination that we either controlled or
condoned a noncompliant advertising practice, there can be no
assurance that we could not be held vicariously liable for the
actions of our independent distributors.
If our
intellectual property is not adequate to provide us with a
competitive advantage or to prevent competitors from replicating
our products, or if we infringe the intellectual property rights
of others, then our financial condition and operating results
would be harmed.
Our future success and ability to compete depend upon our
ability to timely produce innovative products and product
enhancements that motivate our distributors and customers, which
we attempt to protect under a combination of copyright,
trademark and trade secret laws, confidentiality procedures and
contractual provisions. However, our products are generally not
patented domestically or abroad, and the legal protections
afforded by common law and contractual proprietary rights in our
products provide only limited protection and may be
time-consuming and expensive to enforce
and/or
maintain. Further, despite our efforts, we may be unable to
prevent third parties from infringing upon or misappropriating
our proprietary rights or from independently developing
non-infringing products that are competitive with, equivalent to
and/or
superior to our products.
Monitoring infringement
and/or
misappropriation of intellectual property can be difficult and
expensive, and we may not be able to detect any infringement or
misappropriation of our proprietary rights. Even if we do detect
infringement or misappropriation of our proprietary rights,
litigation to enforce these rights could cause us to divert
financial and other resources away from our business operations.
Further, the laws of some foreign countries do not protect our
proprietary rights to the same extent as do the laws of the
United States.
Additionally, third parties may claim that products we have
independently developed infringe upon their intellectual
property rights. For example, in a previously settled lawsuit
Unither Pharma, Inc. and others had alleged that sales by
Herbalife International of (1) its
Niteworks®
and Prelox Blue products and (2) its former products
Womans Advantage with DHEA and Optimum Performance
infringed on patents that are licensed to or owned by those
parties. Although we do not believe that we are infringing on
any third party intellectual property rights, there can be no
assurance that one or more of our products will not be found to
infringe upon other third party intellectual property rights in
the future.
Since
one of our products constitutes a significant portion of our
retail sales, significant decreases in consumer demand for this
product or our failure to produce a suitable replacement should
we cease offering it would harm our financial condition and
operating results.
Our Formula 1 meal replacement product constitutes a significant
portion of our sales, accounting for approximately 31%, 30% and
28% of retail sales for the fiscal years ended December 31,
2008, 2007 and 2006, respectively. If consumer demand for this
product decreases significantly or we cease offering this
product without a suitable replacement, then our financial
condition and operating results would be harmed.
If we
lose the services of members of our senior management team, then
our financial condition and operating results could be
harmed.
We depend on the continued services of our Chairman and Chief
Executive Officer, Michael O. Johnson, and our current senior
management team as they work closely with the senior distributor
leadership to create an environment of inspiration, motivation
and entrepreneurial business success. Although we have entered
into
47
employment agreements with certain members of our senior
management team, and do not believe that any of them are
planning to leave or retire in the near term, we cannot assure
you that our senior managers will remain with us. The loss or
departure of any member of our senior management team could
adversely impact our distributor relations and operating
results. If any of these executives do not remain with us, our
business could suffer. Also, the loss of key personnel,
including our regional and country managers, could negatively
impact our ability to implement our business strategy, and our
continued success will also be dependent on our ability to
retain existing, and attract additional, qualified personnel to
meet our needs. We currently do not maintain key
person life insurance with respect to our senior
management team.
The
covenants in our existing indebtedness limit our discretion with
respect to certain business matters, which could limit our
ability to pursue certain strategic objectives and in turn harm
our financial condition and operating results.
Our credit facility contains numerous financial and operating
covenants that restrict our and our subsidiaries ability
to, among other things:
|
|
|
|
|
pay dividends, redeem share capital or capital stock and make
other restricted payments and investments;
|
|
|
|
incur additional debt or issue preferred shares;
|
|
|
|
impose dividend or other distribution restrictions on our
subsidiaries;
|
|
|
|
create liens on our and our subsidiaries assets;
|
|
|
|
engage in transactions with affiliates;
|
|
|
|
guarantee other indebtedness; and
|
|
|
|
merge, consolidate or sell all or substantially all of our
assets and the assets of our subsidiaries.
|
In addition, our credit facility requires us to meet certain
financial ratios and financial conditions. Our ability to comply
with these covenants may be affected by events beyond our
control, including prevailing economic, financial and industry
conditions. Failure to comply with these covenants could result
in a default causing all amounts to become due and payable under
our credit facility, which is secured by substantially all of
our assets, which the lenders thereunder could proceed to
foreclose against.
If we
do not comply with transfer pricing, customs duties, and similar
regulations, then we may be subjected to additional taxes,
duties, interest and penalties in material amounts, which could
harm our financial condition and operating
results.
As a multinational corporation, in many countries including the
United States we are subject to transfer pricing and other tax
regulations designed to ensure that our intercompany
transactions are consummated at prices that have not been
manipulated to produce a desired tax result, that appropriate
levels of income are reported as earned by our United States or
local entities, and that we are taxed appropriately on such
transactions. In addition, our operations are subject to
regulations designed to ensure that appropriate levels of
customs duties are assessed on the importation of our products.
We are currently subject to pending or proposed audits that are
at various levels of review, assessment or appeal in a number of
jurisdictions involving transfer pricing issues, income taxes,
customs duties, value added taxes, withholding taxes, sales and
use and other taxes and related interest and penalties in
material amounts. For example, we are currently appealing a tax
assessment in Spain. In another matter, in Mexico, we are
awaiting a formal administrative assessment to start the
judicial appeals process. The likelihood and timing of any such
potential assessment is unknown as of the date hereof. The
Company believes that it has meritorious defenses. In some
circumstances, additional taxes, interest and penalties have
been assessed and we will be required to pay the assessments or
post surety, in order to challenge the assessments. The
imposition of new taxes, even pass-through taxes such as VAT,
could have an impact on our perceived product pricing and
therefore a potential negative impact on our business. We have
reserved in the consolidated financial statements an amount that
we believe represents the most likely outcome of the resolution
of these disputes, but if we are incorrect in our assessment we
may have to pay the full amount asserted. Ultimate resolution of
these matters may take several years, and the outcome is
uncertain. If the United States Internal Revenue Service or the
taxing authorities of any other jurisdiction
48
were to successfully challenge our transfer pricing practices or
our positions regarding the payment of income taxes, customs
duties, value added taxes, withholding taxes, sales and use, and
other taxes, we could become subject to higher taxes and our
earnings would be adversely affected. The U.S. Congress is
currently considering various legislative proposals that, if
passed, could require us to modify our current legal entity
structure, the result of which would potentially increase our
effective tax rate and would have an adverse effect on the
Companys financial condition and results of operation.
We may
be held responsible for certain taxes or assessments relating to
the activities of our distributors, which could harm our
financial condition and operating results.
Our distributors are subject to taxation, and in some instances,
legislation or governmental agencies impose an obligation on us
to collect taxes, such as value added taxes, and to maintain
appropriate records. In addition, we are subject to the risk in
some jurisdictions of being responsible for social security and
similar taxes with respect to our distributors. In the event
that local laws and regulations or the interpretation of local
laws and regulations change to require us to treat our
independent distributors as employees, or that our distributors
are deemed by local regulatory authorities in one or more of the
jurisdictions in which we operate to be our employees rather
than independent contractors under existing laws and
interpretations, we may be held responsible for social security
and related taxes in those jurisdictions, plus any related
assessments and penalties, which could harm our financial
condition and operating results.
We may
incur material product liability claims, which could increase
our costs and harm our financial condition and operating
results.
Our products consist of herbs, vitamins and minerals and other
ingredients that are classified as foods or dietary supplements
and are not subject to pre-market regulatory approval in the
United States. Our products could contain contaminated
substances, and some of our products contain some ingredients
that do not have long histories of human consumption. We conduct
limited clinical studies on some key products but not all
products. Previously unknown adverse reactions resulting from
human consumption of these ingredients could occur. As a
marketer of dietary and nutritional supplements and other
products that are ingested by consumers or applied to their
bodies, we have been, and may again be, subjected to various
product liability claims, including that the products contain
contaminants, the products include inadequate instructions as to
their uses, or the products include inadequate warnings
concerning side effects and interactions with other substances.
It is possible that widespread product liability claims could
increase our costs, and adversely affect our revenues and
operating income. Moreover, liability claims arising from a
serious adverse event may increase our costs through higher
insurance premiums and deductibles, and may make it more
difficult to secure adequate insurance coverage in the future.
In addition, our product liability insurance may fail to cover
future product liability claims, thereby requiring us to pay
substantial monetary damages and adversely affecting our
business. Finally, given the higher level of self-insured
retentions that we have accepted under our current product
liability insurance policies, which are as high as approximately
$10 million, in certain cases we may be subject to the full
amount of liability associated with any injuries, which could be
substantial.
Several years ago, a number of states restricted the sale of
dietary supplements containing botanical sources of ephedrine
alkaloids and on February 6, 2004, the FDA banned the use
of such ephedrine alkaloids. Until late 2002, we had sold
Thermojetics®
original green herbal tablets,
Thermojetics®
green herbal tablets and
Thermojetics®
gold herbal tablets, all of which contained ephedrine alkaloids.
Accordingly, we run the risk of product liability claims related
to the ingestion of ephedrine alkaloids contained in those
products. Currently, we have been named as a defendant in
product liability lawsuits seeking to link the ingestion of
certain of the aforementioned products to subsequent alleged
medical problems suffered by plaintiffs. Although we believe
that we have meritorious defenses to the allegations contained
in these lawsuits, and are vigorously defending these claims,
there can be no assurance that we will prevail in our defense of
any or all of these matters.
49
We are
subject to, among other things, requirements regarding the
effectiveness of internal controls over financial reporting. In
connection with these requirements, we conduct regular audits of
our business and operations. Our failure to identify or correct
deficiencies and areas of weakness in the course of these audits
could adversely affect our financial condition and operating
results.
We are required to comply with various corporate governance and
financial reporting requirements under the Sarbanes-Oxley Act of
2002, as well as new rules and regulations adopted by the SEC,
the Public Company Accounting Oversight Board and the New York
Stock Exchange. In particular, we are required to include
management and auditor reports on the effectiveness of internal
controls over financial reporting as part of our annual reports
on
Form 10-K,
pursuant to Section 404 of the Sarbanes-Oxley Act. We
expect to continue to spend significant amounts of time and
money on compliance with these rules. Our failure to correct any
noted weaknesses in internal controls over financial reporting
could result in the disclosure of material weaknesses which
could have a material adverse effect upon the market value of
our stock.
On a regular and on-going basis, we conduct audits through our
internal audit department of various aspects of our business and
operations. These internal audits are conducted to insure
compliance with our policies and to strengthen our operations
and related internal controls. The Audit Committee of our Board
of Directors regularly reviews the results of these internal
audits and, when appropriate, suggests remedial measures and
actions to correct noted deficiencies or strengthen areas of
weakness. There can be no assurance that these internal audits
will uncover all material deficiencies or areas of weakness in
our operations or internal controls. If left undetected and
uncorrected, such deficiencies and weaknesses could have a
material adverse effect on our financial condition and results
of operations.
From time to time, the results of these internal audits may
necessitate that we conduct further investigations into aspects
of our business or operations. In addition, our business
practices and operations may periodically be investigated by one
or more of the many governmental authorities with jurisdiction
over our worldwide operations. In the event that these
investigations produce unfavorable results, we may be subjected
to fines, penalties or loss of licenses or permits needed to
operate in certain jurisdictions, any one of which could have a
material adverse effect on our financial condition or operating
results.
Holders
of our common shares may face difficulties in protecting their
interests because we are incorporated under Cayman Islands
law.
Our corporate affairs are governed by our amended and restated
memorandum and articles of association, and by the Companies Law
(2007 Revision) and the common law of the Cayman Islands. The
rights of our shareholders and the fiduciary responsibilities of
our directors under Cayman Islands law are not as clearly
established as under statutes or judicial precedent in existence
in jurisdictions in the United States. Therefore, shareholders
may have more difficulty in protecting their interests in the
face of actions by our management or board of directors than
would shareholders of a corporation incorporated in a
jurisdiction in the United States, due to the comparatively less
developed nature of Cayman Islands law in this area.
Unlike many jurisdictions in the United States, Cayman Islands
law does not specifically provide for shareholder appraisal
rights on a merger or consolidation of a company. This may make
it more difficult for shareholders to assess the value of any
consideration they may receive in a merger or consolidation or
to require that the offer give shareholders additional
consideration if they believe the consideration offered is
insufficient.
Shareholders of Cayman Islands exempted companies such as
Herbalife have no general rights under Cayman Islands law to
inspect corporate records and accounts or to obtain copies of
lists of our shareholders. Our directors have discretion under
our articles of association to determine whether or not, and
under what conditions, our corporate records may be inspected by
our shareholders, but are not obliged to make them available to
our shareholders. This may make it more difficult for you to
obtain the information needed to establish any facts necessary
for a shareholder motion or to solicit proxies from other
shareholders in connection with a proxy contest.
Subject to limited exceptions, under Cayman Islands law, a
minority shareholder may not bring a derivative action against
the board of directors. Maples and Calder, our Cayman Islands
counsel, has informed us that they are not aware of any reported
class action or derivative action having been brought in a
Cayman Islands court.
50
Provisions
of our articles of association and Cayman Islands corporate law
may impede a takeover or make it more difficult for shareholders
to change the direction or management of the Company, which
could reduce shareholders opportunity to influence
management of the Company.
Our articles of association permit our board of directors to
issue preference shares from time to time, with such rights and
preferences as they consider appropriate. Our board of directors
could authorize the issuance of preference shares with terms and
conditions and under circumstances that could have an effect of
discouraging a takeover or other transaction.
In addition, our articles of association contain certain other
provisions which could have an effect of discouraging a takeover
or other transaction or preventing or making it more difficult
for shareholders to change the direction or management of our
Company, including a classified board, the inability of
shareholders to act by written consent, a limitation on the
ability of shareholders to call special meetings of shareholders
and advance notice provisions. As a result, our shareholders may
have less input into the management of our Company than they
might otherwise have if these provisions were not included in
our articles of association.
Unlike many jurisdictions in the United States, Cayman Islands
law does not provide for mergers as that term is understood
under corporate law in the United States. However, Cayman
Islands law does have statutory provisions that provide for the
reconstruction and amalgamation of companies, which are commonly
referred to in the Cayman Islands as schemes of
arrangement. The procedural and legal requirements
necessary to consummate these transactions are more rigorous and
take longer to complete than the procedures typically required
to consummate a merger in the United States. Under Cayman
Islands law and practice, a scheme of arrangement in relation to
a solvent Cayman Islands company must be approved at a
shareholders meeting by each class of shareholders, in
each case, by a majority of the number of holders of each class
of a companys shares that are present and voting (either
in person or by proxy) at such a meeting, which holders must
also represent 75% in value of such class issued that are
present and voting (either in person or by proxy) at such
meeting (excluding the shares owned by the parties to the scheme
of arrangement).
The convening of these meetings and the terms of the
amalgamation must also be sanctioned by the Grand Court of the
Cayman Islands. Although there is no requirement to seek the
consent of the creditors of the parties involved in the scheme
of arrangement, the Grand Court typically seeks to ensure that
the creditors have consented to the transfer of their
liabilities to the surviving entity or that the scheme of
arrangement does not otherwise have a material adverse effect on
the creditors interests. Furthermore, the Grand Court will
only approve a scheme of arrangement if it is satisfied that:
|
|
|
|
|
the statutory provisions as to majority vote have been complied
with;
|
|
|
|
the shareholders have been fairly represented at the meeting in
question;
|
|
|
|
the scheme of arrangement is such as a businessman would
reasonably approve; and
|
|
|
|
the scheme or arrangement is not one that would more properly be
sanctioned under some other provision of the Companies Law.
|
There
is uncertainty as to shareholders ability to enforce
certain foreign civil liabilities in the Cayman
Islands.
We are incorporated as an exempted company with limited
liability under the laws of the Cayman Islands. A material
portion of our assets are located outside of the United States.
As a result, it may be difficult for our shareholders to enforce
judgments against us or judgments obtained in U.S. courts
predicated upon the civil liability provisions of the federal
securities laws of the United States or any state of the United
States.
We have been advised by our Cayman Islands counsel, Maples and
Calder, that although there is no statutory enforcement in the
Cayman Islands of judgments obtained in the United States, the
courts of the Cayman Islands will based on the
principle that a judgment by a competent foreign court imposes
upon the judgment debtor an obligation to pay the sum for which
judgment has been given recognize and enforce a
foreign judgment of a court of competent jurisdiction if such
judgment is final, for a liquidated sum, not in respect of taxes
or a fine or penalty, is not inconsistent with a Cayman Islands
judgment in respect of the same matters, and was not obtained in
51
a manner, and is not of a kind, the enforcement of which is
contrary to the public policy of the Cayman Islands. There is
doubt, however, as to whether the Grand Court of the Cayman
Islands will (1) recognize or enforce judgments of
U.S. courts predicated upon the civil liability provisions
of the federal securities laws of the United States or any
state of the United States, or (2) in original actions
brought in the Cayman Islands, impose liabilities predicated
upon the civil liability provisions of the federal securities
laws of the United States or any state of the United States, on
the grounds that such provisions are penal in nature.
The Grand Court of the Cayman Islands may stay proceedings if
concurrent proceedings are being brought elsewhere.
|
|
Item 2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
(a) None.
(b) None.
(c) We did not repurchase any common shares during the
three months ended March 31, 2009. As of March 31,
2009 the approximate dollar value of shares that may yet be
purchased under the program was $97.2 million. This share
repurchase program expired on April 17, 2009 pursuant to
its terms.
|
|
Item 3.
|
Defaults
Upon Senior Securities
|
None.
|
|
Item 4.
|
Submission
of Matters to a Vote of Security Holders
|
None.
|
|
Item 5.
|
Other
Information
|
(a) None.
(b) None.
(a) Exhibit Index:
52
EXHIBIT INDEX
|
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
Description
|
|
Reference
|
|
|
2
|
.1
|
|
Agreement and Plan of Merger, dated April 10, 2002, by and
among Herbalife International, Inc., WH Holdings (Cayman
Islands) Ltd. and WH Acquisition Corp.
|
|
|
(a)
|
|
|
3
|
.1
|
|
Form of Amended and Restated Memorandum and Articles of
Association of Herbalife Ltd.
|
|
|
(d)
|
|
|
4
|
.1
|
|
Form of Share Certificate
|
|
|
(d)
|
|
|
10
|
.1
|
|
Form of Indemnity Agreement between Herbalife International Inc.
and certain officers and directors of Herbalife International
Inc.
|
|
|
(a)
|
|
|
10
|
.2
|
|
Office lease agreement between Herbalife International of
America Inc. and State Teachers Retirement System, dated
July 11, 1995
|
|
|
(a)
|
|
|
10
|
.3#
|
|
Herbalife International of America, Inc.s Senior Executive
Deferred Compensation Plan, effective January 1, 1996, as
amended
|
|
|
(a)
|
|
|
10
|
.4#
|
|
Herbalife International of America, Inc.s Management
Deferred Compensation Plan, effective January 1, 1996, as amended
|
|
|
(a)
|
|
|
10
|
.5
|
|
Master Trust Agreement between Herbalife International of
America, Inc. and Imperial Trust Company, Inc., effective
January 1, 1996
|
|
|
(a)
|
|
|
10
|
.6#
|
|
Herbalife International Inc. 401K Profit Sharing Plan and Trust,
as amended
|
|
|
(a)
|
|
|
10
|
.7
|
|
Trust Agreement for Herbalife 2001 Executive Retention
Plan, effective March 15, 2001
|
|
|
(a)
|
|
|
10
|
.8#
|
|
Herbalife 2001 Executive Retention Plan, effective
March 15, 2001
|
|
|
(a)
|
|
|
10
|
.9
|
|
Notice to Distributors regarding
|
|
|
(a)
|
|
|
|
|
|
Amendment to Agreements of Distributorship, dated as of
July 18, 2002 between Herbalife International, Inc. and
each Herbalife Distributor
|
|
|
|
|
|
10
|
.10
|
|
July 31, 2002, by and among WH Holdings (Cayman Islands)
Ltd., WH Acquisition Corp., Whitney & Co., LLC,
Whitney V, L.P., Whitney Strategic Partners V, L.P.,
GGC Administration, L.L.C., Golden Gate Private Equity, Inc.,
CCG Investments (BVI), L.P., CCG Associates-AI, LLC, CCG
Investment Fund-AI, LP, CCG AV, LLC-Series C, CCG AV,
LLC-Series C, CCG AV, LLC-Series E, CCG Associates-QP,
LLC and WH Investments Ltd.
|
|
|
(a)
|
|
|
10
|
.11#
|
|
Independent Directors Stock Option Plan of WH Holdings
(Cayman Islands) Ltd.
|
|
|
(a)
|
|
|
10
|
.12#
|
|
WH Holdings (Cayman Islands) Ltd. Stock Incentive Plan, as
restated, dated as of November 5, 2003
|
|
|
(a)
|
|
|
10
|
.13#
|
|
Non-Statutory Stock Option Agreement, dated as of April 3,
2003 between WH Holdings (Cayman Islands) Ltd. and Michael O.
Johnson
|
|
|
(a)
|
|
|
10
|
.14#
|
|
Side Letter Agreement dated as of April 3, 2003 by and
among WH Holdings (Cayman Islands) Ltd., Michael O. Johnson and
the Shareholders listed therein
|
|
|
(a)
|
|
|
10
|
.15#
|
|
Form of Non-Statutory Stock Option Agreement (Non-Executive
Agreement)
|
|
|
(a)
|
|
|
10
|
.16#
|
|
Form of Non-Statutory Stock Option Agreement (Executive
Agreement)
|
|
|
(a)
|
|
|
10
|
.17
|
|
Indemnity Agreement, dated as of February 9, 2004, among WH
Capital Corporation and Gregory Probert
|
|
|
(a)
|
|
|
10
|
.18
|
|
Indemnity Agreement, dated as of February 9, 2004, among WH
Capital Corporation and Brett R. Chapman
|
|
|
(a)
|
|
|
10
|
.19
|
|
Stock Subscription Agreement of WH Capital Corporation, dated as
of February 9, 2004, between WH Capital Corporation and WH
Holdings (Cayman Islands) Ltd.
|
|
|
(a)
|
|
|
10
|
.20
|
|
First Amendment to Amended and Restated WH Holdings (Cayman
Islands) Ltd. Stock Incentive Plan, dated November 5, 2003
|
|
|
(a)
|
|
|
10
|
.21
|
|
Registration Rights Agreement, dated as of July 31, 2002,
by and among WH Holdings (Cayman Islands) Ltd., Whitney V,
L.P., Whitney Strategic Partners V, L.P., WH Investments
Ltd., CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG
Associates-AI, LLC, CCG Investment Fund-AI, L.P., CCG AV,
LLC-Series C and CCG AV, LLC-Series E.
|
|
|
(b)
|
|
53
|
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
Description
|
|
Reference
|
|
|
10
|
.22
|
|
Share Purchase Agreement, dated as of July 31, 2002, by and
among WH Holdings (Cayman Islands) Ltd., Whitney Strategic
Partners V, L.P., WH Investments Ltd., Whitney V,
L.P., CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG
Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV,
LLC-Series C and CCG AV, LLC-Series E.
|
|
|
(b)
|
|
|
10
|
.23
|
|
Form of Indemnification Agreement between Herbalife Ltd. and the
directors and certain officers of Herbalife Ltd.
|
|
|
(c)
|
|
|
10
|
.24#
|
|
Herbalife Ltd. 2004 Stock Incentive Plan, effective
December 1, 2004
|
|
|
(c)
|
|
|
10
|
.25
|
|
Termination Agreement, dated as of December 1, 2004,
between Herbalife Ltd., Herbalife International, Inc. and
Whitney & Co., LLC.
|
|
|
(d)
|
|
|
10
|
.26
|
|
Termination Agreement, dated as of December 1, 2004,
between Herbalife Ltd., Herbalife International Inc. and GGC
Administration, L.L.C.
|
|
|
(d)
|
|
|
10
|
.27
|
|
Indemnification Agreement, dated as of December 13, 2004,
by and among Herbalife Ltd., Herbalife International, Inc.,
Whitney V, L.P., Whitney Strategic Partners V, L.P.,
CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG
Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV,
LLC-Series C, CCG AV, LLC-Series E, CCG CI, LLC and
GGC Administration, LLC.
|
|
|
(d)
|
|
|
10
|
.28#
|
|
Amendment No. 1 to Herbalife Ltd. 2004 Stock Incentive Plan
|
|
|
(e)
|
|
|
10
|
.29#
|
|
Form of Stock Bonus Award Agreement
|
|
|
(e)
|
|
|
10
|
.30#
|
|
Employment Agreement Effective as of January 1, 2005
between Herbalife Ltd. and Henry Burdick
|
|
|
(f)
|
|
|
10
|
.31#
|
|
Form of 2004 Herbalife Ltd. 2004 Stock Incentive Plan Stock
Option Agreement
|
|
|
(g)
|
|
|
10
|
.32#
|
|
Form of 2004 Herbalife Ltd. 2004 Stock Incentive Plan
Non-Employee Director Stock Option Agreement
|
|
|
(g)
|
|
|
10
|
.33
|
|
Service Agreement by and between Herbalife Europe Limited and
Wynne Roberts ESQ, dated as of September 6, 2005
|
|
|
(h)
|
|
|
10
|
.34#
|
|
Independent Directors Deferred Compensation and Stock Unit Plan
|
|
|
(i)
|
|
|
10
|
.35#
|
|
Independent Directors Stock Unit Award Agreement
|
|
|
(i)
|
|
|
10
|
.36#
|
|
Herbalife Ltd. 2005 Stock Incentive Plan
|
|
|
(j)
|
|
|
10
|
.37#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit
Award Agreement
|
|
|
(k)
|
|
|
10
|
.38#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock
Appreciation Right Award Agreement
|
|
|
(k)
|
|
|
10
|
.39#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit
Award Agreement applicable to Mr. Michael O. Johnson
|
|
|
(l)
|
|
|
10
|
.40#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock
Appreciation Right Award Agreement applicable to
Mr. Michael O. Johnson
|
|
|
(l)
|
|
|
10
|
.41#
|
|
Amendment to Herbalife Ltd. Independent Directors Deferred
Compensation and Stock Unit Plan
|
|
|
(m)
|
|
|
10
|
.42#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit
Award Agreement applicable to Messrs. Brett R. Chapman and
Richard Goudis
|
|
|
(n)
|
|
|
10
|
.43#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock
Appreciation Right Award Agreement applicable to
Messrs. Brett R. Chapman and Richard Goudis
|
|
|
(n)
|
|
|
10
|
.44#
|
|
Employment agreement dated December 18, 2007 between
Herbalife International of America, Inc. and Paul Noack
|
|
|
(o)
|
|
|
10
|
.45
|
|
Form of Credit Agreement, dated as of July 21, 2006, by and
among Herbalife International Inc.,
|
|
|
(p)
|
|
|
|
|
|
Herbalife Ltd., WH Intermediate Holdings Ltd., HBL Ltd., WH
Luxembourg Holdings S.á.R.L., Herbalife International
Luxembourg S.á.R.L., HLF Luxembourg Holdings,
S.á.R.L., WH Capital Corporation, WH Luxembourg
Intermediate Holdings S.á.R.L., HV Holdings Ltd., Herbalife
Distribution Ltd., Herbalife Luxembourg Distribution
S.á.R.L., and the Subsidiary Guarantors party thereto in
favor of Merrill Lynch Capital Corporation, as Collateral Agent
|
|
|
|
|
54
|
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
Description
|
|
Reference
|
|
|
10
|
.46
|
|
Form of Security Agreement, dated as of July 21, 2006, by
and among Herbalife International, Inc., Herbalife Ltd., WH
Intermediate Holdings Ltd., HBL Ltd., WH Luxembourg Holdings
S.á.R.L., Herbalife International Luxembourg S.á.R.L.,
HLF Luxembourg Holdings, S.á.R.L., WH Capital Corporation,
WH Luxembourg Intermediate Holdings S.á.R.L., HV Holdings
Ltd., Herbalife Distribution Ltd., Herbalife Luxembourg
Distribution S.á.R.L., and the Subsidiary Guarantors party
thereto in favor of Merrill Lynch Capital Corporation, as
Collateral Agent
|
|
|
(p)
|
|
|
10
|
.47#
|
|
Amended and Restated Independent Directors Deferred Compensation
and Stock Unit Plan
|
|
|
(p)
|
|
|
10
|
.48#
|
|
Employment Agreement by and between Herbalife Ltd. and Gregory
L. Probert dated October 10, 2006
|
|
|
(q)
|
|
|
10
|
.49#
|
|
Employment Agreement by and between Herbalife Ltd. and Brett R.
Chapman dated October 10, 2006
|
|
|
(q)
|
|
|
10
|
.50#
|
|
Stock Unit Agreement by and between Herbalife Ltd. and Brett R.
Chapman dated October 10, 2006
|
|
|
(q)
|
|
|
10
|
.51#
|
|
Amendment dated October 10, 2006, to Stock Option Agreement
by and between Herbalife Ltd. and Brett R. Chapman dated
September 1, 2004
|
|
|
(q)
|
|
|
10
|
.52#
|
|
Amendment dated October 10, 2006, to Stock Option Agreement
by and between Herbalife Ltd. and Brett R. Chapman dated
December 1, 2004
|
|
|
(q)
|
|
|
10
|
.53#
|
|
Amendment dated October 10, 2006, to Stock Option Agreement
by and between Herbalife Ltd. and Brett R. Chapman dated
April 27, 2005
|
|
|
(q)
|
|
|
10
|
.54#
|
|
Employment Agreement by and between Herbalife Ltd. and Richard
P. Goudis dated October 24, 2006
|
|
|
(r)
|
|
|
10
|
.55#
|
|
Stock Unit Agreement by and between Herbalife Ltd. and Richard
P. Goudis dated October 24, 2006
|
|
|
(r)
|
|
|
10
|
.56#
|
|
Amendment dated October 24, 2006, to Stock Option Agreement
by and between Herbalife Ltd. and Richard P. Goudis dated
June 14, 2004
|
|
|
(r)
|
|
|
10
|
.57#
|
|
Amendment dated October 24, 2006, to Stock Option Agreement
by and between Herbalife Ltd. and Richard P. Goudis dated
September 1, 2004
|
|
|
(r)
|
|
|
10
|
.58#
|
|
Amendment dated October 24, 2006, to Stock Option Agreement
by and between Herbalife Ltd. and Richard P. Goudis dated
December 1, 2004
|
|
|
(r)
|
|
|
10
|
.59#
|
|
Amendment dated October 24, 2006, to Stock Option Agreement
by and between Herbalife Ltd. and Richard P. Goudis dated
April 27, 2005
|
|
|
(r)
|
|
|
10
|
.60#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit
Award Agreement applicable to Michael O Johnson
|
|
|
(s)
|
|
|
10
|
.61#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock
Appreciation Right Award Agreement applicable to Michael O.
Johnson
|
|
|
(s)
|
|
|
10
|
.62#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit
Award Agreement applicable to Messrs. Richard P. Goudis and
Brett R. Chapman
|
|
|
(s)
|
|
|
10
|
.63#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock
Appreciation Right Award Agreement applicable to
Messrs. Richard P. Goudis and Brett R. Chapman
|
|
|
(s)
|
|
|
10
|
.64#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit
Award Agreement
|
|
|
(s)
|
|
|
10
|
.65#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock
Appreciation Right Award Agreement
|
|
|
(s)
|
|
|
10
|
.66
|
|
First Amendment dated June 21, 2007, to Form of Credit
Agreement, dated as of July 21, 2006, by and among
Herbalife International Inc., Herbalife Ltd., WH Intermediate
Holdings Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L.,
Herbalife International Luxembourg S.á.R.L., HLF Luxembourg
Holdings, S.á.R.L., WH Capital Corporation, WH Luxembourg
Intermediate Holdings S.á.R.L., HV Holdings Ltd., Herbalife
Distribution Ltd., Herbalife Luxembourg Distribution
S.á.R.L., and the Subsidiary Guarantors party thereto in
favor of Merrill Lynch Capital Corporation, as Collateral Agent
|
|
|
(t)
|
|
55
|
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
Description
|
|
Reference
|
|
|
10
|
.67
|
|
Second Amendment dated September 17, 2007, to Form of
Credit Agreement, dated as of July 21, 2006, by and among
Herbalife International Inc., Herbalife Ltd., WH Intermediate
Holdings Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L.,
Herbalife International Luxembourg S.á.R.L., HLF Luxembourg
Holdings, S.á.R.L., WH Capital Corporation,
WH Luxembourg Intermediate Holdings S.á.R.L., HV
Holdings Ltd., Herbalife Distribution Ltd., Herbalife Luxembourg
Distribution S.á.R.L., and the Subsidiary Guarantors party
thereto in favor of Merrill Lynch Capital Corporation, as
Collateral Agent
|
|
|
(t)
|
|
|
10
|
.68
|
|
Third Amendment dated November 30, 2007, to Form of Credit
Agreement, dated as of July 21, 2006, by and among
Herbalife International Inc., Herbalife Ltd., WH Intermediate
Holdings Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L.,
Herbalife International Luxembourg S.á.R.L., HLF Luxembourg
Holdings, S.á.R.L., WH Capital Corporation, WH Luxembourg
Intermediate Holdings S.á.R.L., HV Holdings Ltd., Herbalife
Distribution Ltd., Herbalife Luxembourg Distribution
S.á.R.L., and the Subsidiary Guarantors party thereto in
favor of Merrill Lynch Capital Corporation, as Collateral Agent
|
|
|
(u)
|
|
|
10
|
.69#
|
|
Herbalife Ltd. Employee Stock Purchase Plan
|
|
|
(u)
|
|
|
10
|
.70
|
|
Fourth Amendment dated February 21, 2008, to Form of Credit
Agreement, dated as of July 21, 2006, by and among
Herbalife International Inc., Herbalife Ltd., WH Intermediate
Holdings Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L.,
Herbalife International Luxembourg S.á.R.L., HLF Luxembourg
Holdings, S.á.R.L., WH Capital Corporation, WH Luxembourg
Intermediate Holdings S.á.R.L., HV Holdings Ltd., Herbalife
Distribution Ltd., Herbalife Luxembourg Distribution
S.á.R.L., and the Subsidiary Guarantors party thereto in
favor of Merrill Lynch Capital Corporation, as Collateral Agent
|
|
|
(u)
|
|
|
10
|
.71#
|
|
Employment Agreement dated as of March 27, 2008 between
Michael O. Johnson and Herbalife International of America, Inc.
|
|
|
(v)
|
|
|
10
|
.72#
|
|
Stock Unit Award Agreement by and between Herbalife Ltd. and
Michael O. Johnson, dated March 27, 2008.
|
|
|
(v)
|
|
|
10
|
.73#
|
|
Stock Appreciation Right Award Agreement by and between
Herbalife Ltd. and Michael O. Johnson, dated March 27, 2008.
|
|
|
(v)
|
|
|
10
|
.74#
|
|
Stock Appreciation Right Award Agreement by and between
Herbalife Ltd. and Michael O. Johnson, dated March 27, 2008.
|
|
|
(v)
|
|
|
10
|
.75#
|
|
Amendment No. 1 to Employment Agreement dated as of
April 4, 2008 between Gregory L. Probert and Herbalife
International of America, Inc.
|
|
|
(w)
|
|
|
10
|
.76
|
|
Fifth Amendment dated September 25, 2008, to Form of Credit
Agreement, dated as of July 21, 2006, by and among
Herbalife International Inc., Herbalife Ltd., WH Intermediate
Holdings Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L.,
Herbalife International Luxembourg S.á.R.L., HLF Luxembourg
Holdings, S.á.R.L., WH Capital Corporation, WH Luxembourg
Intermediate Holdings S.á.R.L., HV Holdings Ltd., Herbalife
Distribution Ltd., Herbalife Luxembourg Distribution
S.á.R.L., and the Subsidiary Guarantors party thereto in
favor of Merrill Lynch Capital Corporation, as Collateral Agent
|
|
|
(x)
|
|
|
10
|
.77#
|
|
Amendment to Herbalife International Inc. 401K Profit Sharing
Plan and Trust
|
|
|
*
|
|
|
10
|
.78#
|
|
Amendment to Amended and Restated Independent Directors Deferred
Compensation and Stock Unit Plan
|
|
|
*
|
|
|
10
|
.79#
|
|
Form of Independent Directors Stock Appreciation Right Award
Agreement
|
|
|
*
|
|
|
31
|
.1
|
|
Rule 13a-14(a)
Certification of Chief Executive Officer
|
|
|
*
|
|
|
31
|
.2
|
|
Rule 13a-14(a)
Certification of Chief Financial Officer
|
|
|
*
|
|
|
32
|
.1
|
|
Section 1350 Certification of Chief Executive Officer and
Chief Financial Officer
|
|
|
*
|
|
|
|
|
* |
|
Filed herewith. |
|
# |
|
Management contract or compensatory plan or arrangement. |
|
(a) |
|
Previously filed on October 1, 2004 as an Exhibit to the
Companys registration statement on
Form S-1
(File No. 333-119485)
and is incorporated herein by reference. |
56
|
|
|
(b) |
|
Previously filed on November 9, 2004 as an Exhibit to
Amendment No. 2 to the Companys registration
statement on
Form S-1
(File
No. 333-119485)
and is incorporated herein by reference. |
|
(c) |
|
Previously filed on December 2, 2004 as an Exhibit to
Amendment No. 4 to the Companys registration
statement on
Form S-1
(File
No. 333-119485)
and is incorporated herein by reference. |
|
(d) |
|
Previously filed on December 14, 2004 as an Exhibit to
Amendment No. 5 to the Companys registration
statement on
Form S-1
(File
No. 333-119485)
and is incorporated herein by reference. |
|
(e) |
|
Previously filed on February 17, 2005 as an Exhibit to the
Companys registration statement on
Form S-8
(File No. 333-122871)
and is incorporated herein by reference. |
|
(f) |
|
Previously filed on May 13, 2005 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(g) |
|
Previously filed on June 14, 2005 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(h) |
|
Previously filed on September 23, 2005 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(i) |
|
Previously filed on February 28, 2006 as an Exhibit to the
Companys Annual Report on
Form 10-K
for the year ended December 31, 2005 and is incorporated
herein by reference. |
|
(j) |
|
Previously filed on November 22, 2005 as an Exhibit to the
Companys registration statement on
Form S-8
(File No. 129885). |
|
(k) |
|
Previously filed on March 29, 2006 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(l) |
|
Previously filed on March 29, 2006 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(m) |
|
Previously filed on March 30, 2006 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(n) |
|
Previously filed on March 31, 2006 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(o) |
|
Previously filed on December 20, 2007 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(p) |
|
Previously filed on November 13, 2006 as an Exhibit to the
Companys Quarterly Report on
Form 10-Q
for the quarter ended September 30, 2006 and is
incorporated by reference. |
|
(q) |
|
Previously filed on October 12, 2006 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(r) |
|
Previously filed on October 26, 2006 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(s) |
|
Previously filed on May 29, 2007 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(t) |
|
Previously filed on November 6, 2007 as an Exhibit to the
Companys Quarterly Report on
Form 10-Q
for the quarter ended September 30, 2007 and is
incorporated by reference. |
|
(u) |
|
Previously filed on February 26, 2008 as an Exhibit to the
Companys Annual Report on
Form 10-K
for the year ended December 31, 2007 and is incorporated
herein by reference. |
|
(v) |
|
Previously filed on April 7, 2008 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(w) |
|
Previously filed on April 9, 2008 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(x) |
|
Previously filed on November 3, 2008 as an Exhibit to the
Companys Quarterly Report on
Form 10-Q
for the quarter ended September 30, 2008 and is
incorporated by reference. |
57
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
HERBALIFE LTD.
Richard Goudis
Chief Financial Officer
Dated: May 4, 2009
58